Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2007-12-19

Pyridinium Bisretinoids: Synthesis and Photoactivated
Cytotoxicity
Junping Gao
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Biochemistry Commons, and the Chemistry Commons

BYU ScholarsArchive Citation
Gao, Junping, "Pyridinium Bisretinoids: Synthesis and Photoactivated Cytotoxicity" (2007). Theses and
Dissertations. 2384.
https://scholarsarchive.byu.edu/etd/2384

This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion
in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please
contact scholarsarchive@byu.edu, ellen_amatangelo@byu.edu.

Pyridinium Bisretinoids:
Synthesis and Photoactivated Cytotoxicity

by
Junping Gao

A thesis submitted to the faculty of
Brigham Young University
in partial fulfillment of the requirements for the degree of

Master of Science

Department of Chemistry and Biochemistry
Brigham Young University
April 2008

BRIGHAM YOUNG UNIVERSITY

GRADUATE COMMITTEE APPROVAL

of a thesis submitted by
Junping Gao

This thesis has been read by each member of the following graduate
committee and by majority vote has been found to be satisfactory.

Date

Heidi R. Vollmer-Snarr, Chair

Date

Merritt B. Andrus

Date

Steven A. Fleming

Date

Steven W. Graves

ii

BRIGHAM YOUNG UNIVERSITY

As chair of the candidate’s graduate committee, I have read the thesis of
Junping Gao in its final form and have found that (1) its format, citations,
and bibliographical style are consistent and acceptable fulfill university and
department; (2) its illustrative materials including figures, tables, and charts
are in place; and (3) the final manuscript is satisfactory to be graduate
committee is ready for submission to the university library.

Date

Heidi R. Vollmer-Snarr
Chair, Graduate Committee

Accepted for the Department

Date

David V. Dearden
Graduate Coordinator

Accepted for the College

Date

Thomas W. Sederberg
Associate Dean, College of Physical
and Mathematical Sciences

iii

Abstract
This thesis discusses pyridinium bisretinoid compounds (PBRs), which were
prepared for two purposes: 1) to use them as standards for detection of novel
fluorophores in human RPE cells, which may be involved in age-related macular
degeneration (AMD), and 2) to use them in the development of a targeted and triggered
drug delivery system for cancer therapy. We prepared a selection of PBRs using a one-pot
biomimetic method; synthesis, mechanisms for formation, and characterization of these
compounds is described. We also explored the photoreactivity of three novel PBR
compounds and found that these PBRs form oxidation products under blue-light
irradiation. The photoinduced cytotoxity of A2P and A2EE was examined in HL-60 cells.
Results from this work suggest that the PBRs presented have the potential to be involved
in AMD and to be developed into a targeted and triggered drug delivery system for cancer
therapy.
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Chapter 1. Introduction
1.1. Photoreceptor and Retinal Pigment Epithelial Cells
The human eye is made up of three main layers (Figure 1.1). The external layer
contains the sclera and cornea. The middle layer includes an anterior portion consisting of
the iris and ciliary body and a posterior portion containing the choroid. The internal layer
is the retina; the central portion of which is called the macula, which is responsible for
central, high-acuity vision.

Figure 1.1. Adult Human Eye
Photons of light enter the eye through the cornea. This light is focused and travels
through the lens, where it is fine-tuned to focus on the retina. Light travels through the
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layers of cells in the retina as shown in Figure 1.2. The photoreceptors, made up of rods
and cones, receive signals and transfer information from these signals to the optic nerve,
which relays the information to be processed in the brain.

Figure 1.2. Cells in the Retina and RPE
Photoreceptor cells are differentiated neurons containing stacks of photosensitive
disks in their outer segments (OS). The disks include rhodopsin and other bound proteins
named opsins, where photons are captured and visual transduction is processed.1 The
photoreceptors need constant rebuilding through the shedding of their OS and
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phagocytosis in retinal pigment epithelial (RPE) cells. This process consists of several
metabolic and transport reactions and is called “the visual cycle” (Figure 1.3).2

Figure 1.3. The Visual Cycle
The initial step of the visual cycle is the light-activated isomerization of 11-cis
retinal to all-trans-retinal.3 When exposed to light, 11-cis-retinal dissociates from opsin
and changes to the all-trans form. Free opsin is converted into a photosensitive visual
pigment with an empty chromophore pocket and regenerates by binding another molecule
of 11-cis-retinal. All-trans-retinal is reduced to all-trans retinol by all-trans-retinol
dehydrogenase after it is transferred from the interior membrane disk to the photoreceptor
outer segment.4 The all-trans-retinol is moved through an extracellular compartment, the
interphotoreceptor matrix (IPM), to the RPE. In the RPE, all-trans-retinol is metabolized
3

to the 11-cis conformation by esterification, isomerization, and oxidation—all steps that
occur in darkness. The newly produced 11-cis retinal moves from the RPE back to the
photoreceptors, where it binds to opsin again and starts a new visual pigment cycle.
One side of the photoreceptor cells connects to the apical portion of horizontal
cells and bipolar cells, and the other side connects to the apical portion of the RPE. The
RPE is a monolayer of cells that lies between the OS of photoreceptors and Bruch’s
membrane (Figure 1.2). The RPE has no photoreceptive or neural functions, but it
supports the viability of the photoreceptors and plays an important role in photoreceptor
growth and maturation.4, 5 The RPE acts as a barrier, called the blood-retinal barrier, by
selectively pumping metabolites and because of its tight intercellular junctions. This
barrier prevents the passage of larger or harmful chemicals to the retina, thereby
providing a stable and clean retinal environment.6-8
The apical layer of the RPE contains microfilaments, microtubules, and highly
concentrated melanin granules. Melanin is a heterogeneous polymer consisting of various
monomers that come from oxidation products of dihydroxyphenylalinine derived from
tyrosine.9 The melanin in the RPE acts as a photoprotective species by absorbing
radiation and consuming free radicals and reactive oxygen species (ROS).10 The rods and
cones are very sensitive to light, and any reflected or scattered light could cause light
damage on the photosensitive retina leading to a loss of image signals. The RPE is thus
viewed as a protector of photosensitized rods and cones.

4

1.2. Age-related Macular Degeneration
Age-related macular degeneration (AMD) is a condition of advanced degeneration
of central vision. AMD occurs as a result of the cellular (photoreceptor and RPE)
degeneration in the central part of the retina called the macula, when photoprotective
melanin pigments have degraded, because of age. AMD affects nearly 20% of people
between the ages of 65 and 75 and greater than 35% of people over the age of 75.11 It is
the leading cause of blindness in developed countries. The disease severely compromises
visual tasks such as reading, facial recognition (Figure 1.4), and depth perception.

Figure 1.4. Normal Vision (right) and Advanced AMD (left)
There are two main types of AMD, the exudative or wet form, and the atrophic or
dry form. Both types of AMD may be caused by oxidative stress. Although there are
many mechanisms in the retina to prevent and reduce oxidative stress, many of these
mechanisms become less effective over time, which is why the risk of contracting AMD
increases with age.12 Despite the rising prevalence of AMD as a result of increasing life

5

expectancy, its underlying pathogenesis is poorly understood, and limited treatment
options are available.
Exudative AMD affects only 10% of the people with this disease and is caused by
abnormal growth of blood vessels in the back of retina. This abnormal blood vessel
growth leads to hemorrhage, exudation, or serious retinal detachment.13 Exudative AMD
is also linked to the accumulation of ROS, which may damage the blood-retinal barrier
formed by the RPE; this damage results in sudden blindness when the vessels leak or
rupture.14 Laser therapies, including photodynamic therapy, have been used to treat
exudative AMD.
Atrophic AMD is the most common form of AMD, which affects 90% of the
people with this disease and occurs when the light-sensitive photoreceptor and RPE cells
in the macula are deteriorated by ROS stress.15 Because both photoreceptor and RPE cells
are non-replicating (post-mitotic), and they will not reproduce after they have matured,
they are often greatly depleted after years of oxidative insult.16 Currently no treatments
exist for atrophic AMD.
Two factors have been implicated in the cause of atrophic AMD: 1) the formation
of drusen, and 2) the accumulation of fluorescent lipofuscin in RPE cells.17-20 Some of the
synthetic compounds described in this thesis (Chapter 2) may be present in RPE
lipofuscin.
Drusen consists of small yellowish, extracellular materials such as lipid, protein,
and cellular debris, existing beneath the RPE.21 Soft drusen, characterized by deposits in
6

the macula without visual loss, are considered to be a precursor to advanced AMD.22, 23
Soft drusen accumulates over time between the RPE and Bruch's membrane, making
Bruch's membrane thicker, and impacting the transportation and diffusion of nutrients
and oxygen between the RPE and the choroid.24 Gradually drusen significantly affects the
blood-retinal barrier, the RPE’s operation, and leads to atrophy of the RPE and adjacent
support membrane, resulting in advanced AMD.25
Lipofuscin (LF) or “aging pigment,” is thought to be another possible biomarker
in the development of AMD.26, 27 LF is a deposit of indigestible waste of oxidative debris
from postmitotic cells in the aging process. LF is a heterogeneous complex of fluorescent,
lipid-protein aggregates, the exact composition of which is poorly understood. In vitro
experiments show that some pigments in LF gradually interrupt the phagocytosis of the
RPE by engendering phototoxic ROS such as singlet oxygen, superoxide radical anion,
and hydrogen peroxide.28 For this reason, identification of the fluorescent pigments in LF
might help in clarifying the mechanism of atrophic AMD and preventing its occurrence.
Analysis of these pigments has shown that they contain the retinoid, all-trans-retinol,
coming from the chemical visual cycle (Figure 1.3), as well as the bisretinoid compounds,
A2E (1) and iso-A2E (2) (Figure 1.5).29 Recently Fishkin et al. 30 reported that they found
the presence of another fluorophore, the all-trans-retinal dimer conjugate (3) (Figure 1.6),
in LF extracts.
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Figure 1.5. Structures of A2E and iso-A2E

R = phospholipid
H

OR
N
H

conjugate, 3

Figure 1.6. all-trans-retinal dimer conjugate

1.3. Identification and Synthesis of A2E
In 1988, Eldred and Katz 31 first reported that several blue-absorbing
chromophores were separated from RPE cellular extracts. Five years later, Wolf 32 found
by performing thin layer chromatography (TLC) analysis on the extracts that the
chromophores they studied were a mixture of several fluorescent components. These
fluorescent chromophores or fluorophores were hypothesized to be the source of
phototoxicity in RPE LF. One of these fluorophores was purified and studied by mass
spectrometry (MS) and found to have a mass of 592.4520 and a molecular formula
C42H58NO.29 Eldred proposed the structure of the isolated fluorophore to be a bisretinoid
8

compound, but did not get the structure exactly right.33, 34 In 1996, Sakai et al.35 correctly
identified the structure as a pyridinium bisretinoid using MS and NMR techniques. The
IUPAC name of this structure is 2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)
-1E,3E,5E,7E-octatetraenyl]1-(2-hydroxyethyl)-4-[4-methyl-6-(2,6,6-trimethyl-1-cyclohe
xen-1-yl)-1E,3E,5E-hexatrienyl]-pyridinium (Figure 1.5). Because the molecule is a
combination of two vitamin A aldehyde (all-trans-retinal) molecules and one molecule of
ethanolamine, it was called A2E.35, 36 Two years later Reinboth et al.37 detected the
presence of A2E in albino rat eyes using high-performance liquid chromatography
(HPLC). Parish and coworkers38 used HPLC and NMR to identify the presence of
all-trans-A2E and the 13'-cis isomer of A2E (iso-A2E) the following year. Ben-Shabat et
al.39 found that all-trans-A2E and iso-A2E reach equilibrium in a 4:1 ratio if pure
all-trans-A2E is exposed to room light. The appearance of up to seven isomers was
observed in an improved HPLC assay, after all-trans-A2E was exposed to room light for
35 minutes. All the isomers have similar UV spectra and the same MS data as
all-trans-A2E. Because all-trans-A2E is unstable and easily isomerizes, the term “A2E”
in this thesis means a collection of all these isomers, in which most of them are
all-trans-A2E and 13'-cis-A2E.
Sakai et al. 35 first reported a biomimetic synthesis of A2E with only a 0.5 % yield
after extensive chromatography. Later, Parish et al.38 reported a one-step biomimetic
preparation of A2E achieving 49% yield after purification via silica gel column
chromatography. They prepared A2E in only one pot with a 2:1:1 mixture of
9

all-trans-retinal, ethanolamine, and acetic acid. Parish attributed the reasons for the
increase in yield of A2E to the addition of one equivalent of acetic acid and to the use of
ethanol as a solvent. This optimized methodology of the one-pot biomimetic synthesis
has made it possible to make large quantities of A2E for use in biological studies.
Ren et al. 40 completed A2E’s first total synthesis and produced a mixture of A2E
isomers in the ratio of 4:3:3:2, which can be 90% converted to the all-trans isomer by
heating and refluxing overnight in nitromethane in the absence of light. Following Ren’s
preparation of A2E, Tanaka et al. 41 improved the total synthesis of A2E by decreasing
the number of steps. Recently Sicre et al.42 reported a convergent total synthesis of A2E.
Although Sicre’s method represents a stereoselective preparation of A2E, it still required
10 steps with an overall yield of only 14%.
Of the syntheses reported, the one-step method proposed by Parish 38 is the best
choice, because of the efficiency and yield. The proposed mechanism for formation of
A2E using this one pot biomimetic preparation is illustrated in Scheme 1.1.35 First, one
all-trans-retinal molecule 4 reacts with ethanolamine to form a Schiff base intermediate 6.
This molecule 6 undergoes a 1,5-H shift to afford an intermediate enamine 7. The
enamine 7 reacts with a second all-trans-retinal molecule to give an iminium ion 8. This
iminium 8 proceeds through an aza-6π-electrocyclization to afford A2E’s precursor 9.
Compound 9 undergoes an auto-oxidation to yield the final product A2E 1.
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Scheme 1.1 Biomimetic Synthesis of A2E

Disputes about where A2E 1 is biosynthesized have been ongoing. Eldred 36
reported that the formation of A2E 1 starts in the acidic RPE lysosomes, and if A2E 1 can
not be digested it accumulates in the lysosomes. Parish proposed that the formation of
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A2E takes place in the photoreceptor OS, which are eventually phagocytosed to the RPE.
To determine the actual mechanism of A2E’s formation, Liu et al.43 explored the
biosynthesis of A2E using in vitro experiments. The results suggest that all-trans retinal 4
first reacts with phosphatidylethanolamine (PE) to form A2PE (10) (Figure 1.7), which
was then hydrolyzed to A2E 1. A2PE (10), which was consequently considered a
precursor of A2E 1, was only detected in the OS and not in RPE. This finding suggests
that the biosynthesis of A2E 1 begins in the photoreceptor OS.

R2
O
N

O

O

O
P
O

O
R1

H

O

O

A2PE, 10

Figure 1.7. Structure of A2PE
R1 and R2 represent biological lipids

To elucidate more of the biosynthetic details of A2E 1, Ben-Shabat et al.39
incubated bovine retinas with exogenous all-trans-retinal. After this incubation, A2PE 10
was isolated from the retinas. The authors went on to investigate the details of the
hydrolysis of A2PE 10.
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A2PE 10 was incubated in an environment similar to the lysosome for 24 hours,
however no A2E 1 was found. In addition, only a tiny amount of A2PE 10 was converted
to A2E 1 after a one week incubation. When A2PE 10 was incubated in bovine OS with
OS specific enzymes, A2PE 10 was converted to A2E 1. According to the results of the
experiments, A2PE 10 appears to be less able to convert to A2E 1 in the RPE, but does
convert to A2E 1 in the OS. Thus, these experiments suggest that the biosynthesis of A2E
occurs entirely in the OS. A2E must enter the RPE when the OS are phagocytosed.
Because A2E is not enzymatically degraded during this process, it is deposited in the
RPE as LF and builds up over time.

1.4. Toxicity of A2E
A2E’s effects on lysosomal function, mitochondrial proteins, and cellular
membranes have been studied extensively. A summary of the findings is reported below.
Overall, the non-photoirradiative effects of A2E described below are minimal compared
to the phototoxicity that will be described in the next section (1.5).
There have been several studies of A2E’s effect on lysosomal function. The first
study was reported by Eldred.36 He proposed that A2E is able to inhibit lysosomal
function and suggested that A2E behaves similarly to quaternary amines, which form
complexes with enzymes. Schutt et al. 44 made a similar observation, and they found that
the accumulation of A2E in the lysosome raises the pH of the lysosome. Holz et al. 45
incubated RPE cells with A2E and found that A2E is a dose-dependent and selective
13

inhibitor of lysosomal function. The in vivo experiment performed by Bermann et al.46
revealed that A2E does not inhibit the lysosomal hydrolases directly but affects other
lysosomal pathways. Finnemann et al.47 incubated RPE cells with A2E for 6 hours and
found that the rate at which RPE cells degrade the OS lipids was decreased, especially the
phosphatidylcholine, the most abundant lipid in the OS. It was proposed that this decrease
in phosphatidylcholine degradation results from A2E’s selective inhibition of
phagolysosomal degradation, which results in accumulation of undigested lipids over
time in RPE cells.
A2E’s effect on mitochondrial function has also been studied. Suter et al.48
incubated A2E with murine cerebellar granule cells, which have a high concentration of
mitochondria. Two proapoptotic proteins, cytochrome c and apoptosis-inducing factor,
were released, and the mitochondrial function was disrupted when the concentration of
A2E was more than 10 μM. It was proposed that A2E facilitates the detachment of
cytochrome c from the mitochondria, leading to apoptosis. Additional experiments on
mitochondria isolated from rat livers demonstrated different effects between A2E
isomers.49 All-trans-A2E decreases the oxygen consumption of the mitochondria,
whereas the 13'-cis isomer had no effect. Additionally, A2E was found to bind tightly
with cytochrome c oxidase and produce more ROS, loading extra oxidative stress on RPE
cells.
The disruption of cell membranes by A2E has also been studied. The positive
charge on the pyridinium ring combined with the two hydrophobic retinoid side chains in
14

A2E make it function like a detergent. This property enables A2E to bind the lipids in cell
membranes and disrupt the integrity of the membranes. Sparrow et al.50 incubated RPE
cells with A2E to examine the effect of the amphiphilic property of A2E in RPE cells. It
was concluded that disruption of RPE cell membranes by A2E is dependent on its
concentration. Schutt et al.51 examined the effect of A2E on the integrity of cellular
organelle membranes. The results revealed that the membrane integrity was destroyed by
very low concentrations of A2E, 1 μM A2E in the mitochondria, 2 μM A2E in the
lysosomes, and 5 μM A2E in the microsomes. Other retinoids and detergents have similar
effects on membrane integrity and induce apoptosis by lysosomal leakage. It was
proposed that A2E might arouse the degeneration of organelle membranes and induced
apoptosis. De and Sakmar 52 explored the effect of A2E on model membranes by
checking the aggregation concentration of A2E in water through fluorescence anisotropy.
The results demonstrated that the concentration of A2E required for the instigation of
membrane solubilization depended on the lipid composition of the vesicle.

1.5. Photoinduced Toxicity of A2E
The phototoxicity of A2E has been extensively studied. Sparrow et al.53 incubated
human RPE (ARPE-19) cells with A2E. These cells were exposed to blue and green light.
Cell death increased with increased blue light exposure and increased concentrations of
A2E. Green light exposure did not cause cell death. Neither blue light exposure without
A2E or A2E in RPE cells without light exposure caused cell death. In the same paper,
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DNA damage was also observed after blue light exposure in A2E-loaded cells. This
damage was also dose and exposure-time dependent.
Sparrow et al. 54 also explored the effect of singlet oxygen in the photoinduced
toxicity of A2E. It was hypothesized that singlet oxygen plays a role in the photoinduced
toxicity of A2E. To test this hypothesis, RPE cells loaded with A2E were exposed to blue
light in the presence and absence of molecular oxygen. Cell death decreased significantly
in cell cultures incubated with oxygen depleters (histidine, sodium azide,
1,4-diazabicyclooctane, and 1,3-dimethyl-2-thiourea), which remove the oxygen
dissolved in the solution. Moreover, A2E-loaded cells that remained in the dark and were
incubated with oxygen depleters incurred no cell death. To further investigate the
hypothesis that singlet oxygen plays a role in cell death, RPE cells loaded with A2E were
incubated in a salt buffer of D2O, which is well known to enhance the lifetime of singlet
oxygen. Cell death in D2O treated cells was increased by 66 % after irradiation with blue
light.
In the same paper, the authors explored the possible products of A2E oxidation.
They observed that the UV-vis absorbance of light–exposed A2E decreased, which
suggested a loss of conjugation in the light–exposed compound. The photo–irradiation
products of A2E were analyzed by fast atom bombardment-mass spectrometry
(FAB-MS); a series of peaks were observed in increments of +16 atomic mass units,
suggesting that oxygen was adding to A2E. The same +16 peaks were observed after
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A2E-loaded RPE cells were irradiated with blue light; these photo-oxidation products
were not found in A2E-loaded RPE cells without irradiation.
Ben-Shabat et al. 55 examined the structures of these oxidation products and
concluded that that the double bonds of A2E reacted with singlet oxygen to form
A2E-epoxides (Figure 1.8). FAB-MS showed 9 peaks after the 592 peak (m/z of A2E),
each at increments of +16, starting with 608 and ending at 736. The m/z 736 was
postulated to be nonaoxirane (11). NMR characterization of the reaction product of A2E
and meta-chloroperbenzoic acid (MCPBA) revealed that the 7, 8, 7', 8'-bisoxirane (12)
might also form during the irradiation. Additional experiments were performed to
investigate whether the irradiation of A2E produced singlet oxygen. The rate of
photo-oxidation increased three times when A2E was irradiated in D2O compared to
irradiation in H2O. When A2E was irradiated in CHCl3, a 1270 nm absorbance was
observed, which typically suggests the presence of singlet oxygen. It was concluded that
A2E is a photosensitizer and produces singlet oxygen from triplet oxygen dissolved in
solution; this singlet oxygen reacts with A2E to form A2E-epoxides.
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Figure 1.8. Products of A2E Photo-oxidation

After the A2E-epoxide structures were proposed, Sparrow et al.56 explored the
cellular toxicity of these purported A2E oxidation products. RPE cells were incubated
with photoirradiated A2E as opposed to previous experiments in which the RPE cells
loaded with A2E were irradiated. Alkaline comet assays were used to examine the effect
of the A2E photoproducts on RPE cells. The assay results showed that the DNA of the
cells incubated with the A2E oxidation products was severely damaged compared with
the cells exposed to unirradiated A2E. Sparrow & co-workers suggested that A2E may be
quenching singlet oxygen, and in turn the A2E oxidation products are causing the cellular
damage. They proposed that the epoxides were acting as electrophiles and reacting with
the DNA directly leading to cell death.
Dillon et al. 57 reported that two of the photooxidation products of A2E might be a
monofuran-A2E (Figure 1.9, 13) and a 5, 8, 5', 8'-bisfuran–A2E (14) based on NMR
analysis and the fragmentation patterns in tandem mass spectrometry. They suggested
that these may be the oxidation products that are present in RPE cells and that epoxides
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are simply fleeting intermediates. Jang et al.58 investigated the photo-oxidation products
of A2E by reacting A2E with 1,4-dimethylnaphthalene endoperoxide, a singlet oxygen
producer. They found that peroxides 15 and 16 were formed and proposed that they may
also be forming in the RPE.
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Figure 1.9. Putative Products of A2E Photo-oxidation
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The oxidation of A2E is a debated and complicated area of study. Although the
structures and the amount of singlet oxygen that A2E produces is under debate, it is clear
that whatever happens when A2E is photo-oxidized, the photo-oxidation prodcucts of
A2E cause significant damage to RPE cells. This damage may contribute to the cellular
atrophy associated with AMD.

1.6. Development of a Targeted and Triggered Drug Delivery System for Cancer
Therapy
The phototoxicity of A2E in RPE cells was detailed in the preceding section.
Because photoirradiated A2E effectively kills RPE cells, we proposed that it might have
similar reactivity in cancer cells. We decided to harness this reactivity and use PBRs to
develop a triggered drug delivery system for cancer. Although not described in this thesis,
in our laboratory, we are also attaching the PBRs to folic acid (17), because of the ability
of folate bioconjugates to target cancer cells.59-66
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N
N
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COOH
O

Figure 1.10. folic acid (17)

1.7. Novel Pyridium Bisretinoid Compounds
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In this thesis we describe the preparation of a library of pyridium bisretinoids
(PBRs), which are analogs of A2E. Because the majority of the composition of LF, which
is implicated in the cause of AMD, remains unknown, these compounds can be used to
identify novel fluorophores in human RPE LF. Evidence suggests that A2E plays a role in
the cause of AMD; therefore, other PBRs, which may also form in the photoreceptor OS
may also be involved in the pathology of AMD. For this purpose biogenic amines which
are likely present in the human retina including, tyramine (18), L-serine (19), guanine
(20), cytosine (21), histidine (22), arginine (23), propanolamine (24), cysteamine (25),
N-(3-aminopropyl)-1,3- propanoldiamine (26), 2-(2-aminoethoxy) ethanol (27),
2-(2-aminoethylamino) ethanol (28), octanamine (29), and 1-amino-2-propanol (30) were
reacted with all-trans-retinal in an attempt to form additional PBRs (Figure 1.11). The
PBRs resulting from this synthesis will be used as standards for their detection in RPE
cells.
Because unoxidized A2E is not significantly toxic in RPE cells at low
concentrations and becomes cytotoxic after photo-oxidation with blue light, we decided
to assess the potential of PBRs, in addition to A2E, for triggered cytotoxicity on cancer
cells. Two amines, aminoacetaldehyde dimethyl acetate (Figure 1.11, 31) and
aminoacetaldehyde diethyl acetate (Figure 1.11, 32), in addition to those described above
were reacted with all-trans-retinal to build a PBR library. A small selection of these
compounds were tested for cancer cell cytotoxicity.

21

The synthetic details of PBRs and mechanisms for their formation are discussed
in Chapter 2. The blue-light photoreactivity of the synthesized compounds is described in
Chapter 3. Cytotoxicity studies of photoirradiated PBRs in HL-60 cells are detailed in
Chapter 4.
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Chapter 2. Synthesis of Pyridinium Bisretinoids & the All-Trans-Retinal Dimer
2.1. Introduction
The goal of the work in this chapter was to synthesize a library of pyridinium
bisretinoid (PBR) compounds to be used as standards for detection in lipofuscin (LF) and
to be studied for their therapeutic potential against cancer. We compared two one-pot
biomimetic methods for their synthesis, one used by Parish et al.1 in the synthesis of
A2-ethanolamine (A2E) and the other used by Pezzella and Prota2 in the synthesis of
A1-dopamine (A1D). Because ion-exchange occurs during chromatography, the acetate
anion is the counter ion for all the PBRs reported. Each PBR is named as A2X, where A
represents vitamin A, and X represents the amine.
Although the yields resulting from the one-pot syntheses are low, they are similiar
to the overall yields in the 7-9 step total synthetic routes reported in the literature3-4 and
attempted in our laboratory. It is therefore more economical and timely to pursue one-pot
syntheses, instead of total synthetic routes. Despite the low yields obtained in these
reactions, the syntheses of PBRs described in this chapter represent straightforward,
biomimetic methods for obtaining a wide variety of compounds, which may have
significant biological importance.
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2.2. Synthesis of A2-Tyramine
We compared the efficacy of the two one-pot biomimetic methods described
above in reactions between ATR and tyramine (18) (Table 2.1). Parish’s A2E
methodology was used in reactions 1, 3, and 4, and Pezzela’s A1D methodology was used
in reaction 2.
To optimize the reaction conditions, parallel reactions were set up and monitored
by thin layer chromatography (TLC). In reactions 1 and 4, most of the starting material
had been consumed in 24 hours, and the reactions went to completion in 48 hours. In
reactions 2 and 3, the reaction rates were much slower than those of reactions 1 and 4;
some of the ATR starting material still remained after 48 hours. Table 2.1 summarizes the
conditions used in each reaction and the resulting yields of A2-tyramine (A2T, 33)
obtained.
As shown in Table 2.1, reaction 1 produced the highest yield. The mechanism for
formation of A2T using reaction conditions described in reaction 1 should be comparable
to that for A2E illustrated in Chapter 1 (Scheme 1.1). The acidic conditions promote the
reaction to move forward to products because the aldehyde is protonated and therefore
becomes more electrophilic. Consequently, the amine attacks the carbonyl more easily,
thereby facilitating conversion to the product. Additionally, the solvent in reaction 2 is
aqueous phosphate buffered saline (PBS) with sodium dodecyl sulfate (SDS). The
presence of water inhibits the formation of key Schiff base intermediate 6 (Scheme 1.1).
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We therefore chose to continue to synthesize A2T and the other PBRs described in this
thesis according to the procedure used in reaction 1.
Table 2.1 Synthesis of A2 -Tyramine

H

H2N

OH

O

O
O

solvent, acid

OH
N

ATR, 4

Reaction

1

Solvent

ethanol

A2T, 33

Time (h)

Acid

acetic acid

O

% yield

48

15

48

5

56

12

48

14

OH

2

aqueous PBS

3

ethanol

p-toluenesulfonic
acid

4

ethanol

trif luoroacetic acid

O
S OH
O
O
F3C

OH

2.3. Reactions of All-Trans-Retinal with Selected Amino Acids
L-serine (19), guanine (20), cytosine (21), histidine (22) and arginine (23) (Figure
1.11) were reacted with ATR using the same conditions described for reaction 1 (Table
2.1). Progress in the reactions were monitored by MS, but no target compounds were
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observed. Each of the amino acids reacted has a 2° amine and either a carboxylic acid or
amide in their structure. Because the 2° amine is more sterically hindered than the 1°
amine in tyramine (18), this steric hindrance may have prevented the reaction with the
ATR aldehyde (4). Protection of the carboxylic acid or amide groups may have also aided
the synthesis, but because we desired the synthesis to be one-pot, we did not attempt
these protections. Instead we focused on the reaction of several 1° amines (both biogenic
and unnatural) that possessed longer hydrocarbon chains lacked carboxylic acids and
amides in their structures.

2.4. Reactions of All-Trans-Retinal with Ethanolamine, Propanolamine, &
Cysteamine
Ethanolamine (2-aminoethanol, 5), propanolamine (3-aminopropan-1-ol, 24), and
cysteamine (2-aminoethanethiol, 25) were reacted with ATR using the same conditions
described for reaction 1 (Table 2.1). The yields of these reactions are summarized in
Table 2.2. Reactions with ethanolamine and propanolamine resulted in the formation of
the corresponding PBRs, whereas no PBR was observed in the reaction with cysteamine.
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Table 2.2 Reactions of All-Trans-Retinal with Aminoalcohols and Aminothiol

O
H
O

+

H2N

R

O

H
EtOH

N

PBRs

ATR, 4

Entry

Amine's Name

1

Ethanolamine, 5

2

Propanolamine, 24

3

R

Cysteamine, 25

R=

%YIELD

OH

OH

SH

18

13

0

18% is obtained by our lab and 49% was the litrature value.

Reaction of ethanolamine and ATR produced A2-ethanolamine (A2E, 1) in 18 %
yield. This yield differs from the value reported in the literature (49 %),1 because the
literature value may represent a crude yield. The reaction with ethanolamine was
attempted several times in our laboratory, and we were unable to get the yield of pure
material to exceed 18 %. In order to obtain pure material, 2 – 3 chromatographic columns
were necessary, which resulted in lower yields.
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The optimized reaction between propanolamine and ATR produced A2propanolamine (A2P, 34) in 13 % yield. This reaction was also attempted several times
and required extensive chromatography for product purification.
H2N
path A

SH
H
O

path B
HS
14

path B

SH

HN

N
enamine, 7a

iminium ion, 8a

HS
14

N

intermediate, 8a'

N

SH

intermediate, 9a

Scheme 2.1 Reaction of All-Trans-Retinal and Cysteamine

No PBR product was observed in the reaction between cysteamine and ATR.
Several obstacles to the A2-cysteamine (A2Cys, 35) exist. Sulfur is more nucleophilic
than the nitrogen, so sulfur would likely attack the ATR aldehyde more readily than
nitrogen. If nitrogen did attack the ATR aldehyde to form the Schiff base, then the sulfur
would still have a higher probability than nitrogen to attack the second ATR aldehyde
(path A in Scheme 2.1). However, if iminium ion 8a did form, the sulfur might attack
carbon 14 adjacent to the iminium ion to give the 5 member ring intermediate 8a' (path B
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in Scheme 2.1). Cysteamine’s sulfur is a better nucleophile than the oxygen in
ethanolamine and propanolamine, so sulfur is more likely to form the proposed 5 member
ring intermediate than oxygen. As demonstrated, there are at least 3 major barriers to the
formation of A2Cys.

2.5. Reactions of All-Trans-Retinal with Polyamines and Hydroxylamines
N-(3-Aminopropyl)propane-1,3-diamine (NPD, 26), 2-(2-aminoethoxy)ethanol
(EE, 27), and 2-(2-aminoethylamino)ethanol (EAE, 28) were reacted with ATR using the
same conditions described for reaction 1 (Table 2.1). The yields of these reactions are
summarized in Table 2.3. Reactions with 27 resulted in the formation of the
corresponding PBR, whereas no PBRs were observed in the reactions with 26 and 28.
After attempting to synthesize A2NPD (36) using reaction 1 methodology, no PBR
products were observed. As a result, we tried using the methodology described in reaction
2 (Table 2.1). Disappointingly, the desired PBR products were not observed after the
reaction was checked at 48 h, 72 h, 96 h and 7 days (Table 2.3).
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Table 3. Reactions of All-Trans-Retinal with Polyamines
and Hydroxylamines

O

H
O

acetic acid

O

amines

ATR, 4

N

R

PBRs
Entry

1

2

3

Amine

PBRs' name

N
NH2
H
N -(3-aminopropyl)propane-1,3-diamine, 26

A2NPD, 36

one week

0

A2EE, 37

48 h

16

A2EAE, 38

96 h

0

H2N

H2N

O

OH

2-(2-aminoethoxy)ethanol, 27

H2N

H
N

OH

Time

% Yield

2-(2-aminoethylamino)ethanol, 28

In an attempt to obtain a PBR product, we decided to replace the 2° and one of the
1° nitrogens in NPD with oxygen atoms. In addition, the carbon chains are each 1 carbon
shorter. EE was reacted with all-trans-retinal to give A2EE (37) in 16 % yield. After
forming A2EE in an acceptable yield for PBR synthesis, we reasoned that a 6-membered
ring intermediate may be forming, similar to the proposed 5-membered ring in the
attempted A2Cy synthesis (Scheme 2.2).
In order to further probe the proposed 5- and 6-membered ring formation, we
attempted the reaction with the 2° nitrogen in EE exchanged with an oxygen atom. When
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EAE was reacted with all-trans-retinal no A2EAE (38) was observed (Table 2.3). In this
reaction a 5-membered ring intermediate likely forms, suppressing the formation of
A2EAE (Scheme 2.2).

H
O

NH 2
HN

( )n

HN

NH2
( )n

NH
( )n

( )n

N

enamine, 7b
n = 1, 2
iminium, 8b

NH 2
( )n
HN ( )
n
14

N

intermediate, 8b'

N

( )n

NH

( )n

NH 2

intermediate, 9b

Scheme 2.2 Attempted Synthesis of A2NPD and A2EAE

As pictured in Scheme 2.2 iminium 8b can’t proceed to the PBR 9b because the
amino groups in NPD and EAE may attack the carbon adjacent to the iminium ion and
return to 7b through the 5 or 6 member ring 8b'. The A2EE preparation succeeded
because the ether oxygen is not a strong enough nucleophile to break the carbon nitrogen
bond of the iminium ion.
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2.6. Reactions of All-Trans-Retinal with Additional Amines
Aminoacetaldehyde dimethyl acetate (DM, 31), aminoacetaldehyde diethyl
acetate (DE, 32), 2-octanamine (OA, 29), 1-amino-1-propanol (AP, 30), and
S-1-amino-2-propanol (S-AP, 30-S) were reacted with ATR using the same conditions
described for reaction 1 (Table 2.1).

Table 2.4 Reactions of All-Trans-Retinal with Additional Amines

O

H
O

+

H2N

R

H

O

EtOH

N
ATR, 4

R

PBRs

Entry

Amine

PBR's name

1

aminoacetaldehyde
dimethyl acetate, 31

A2DM, 39

2

aminoacetaldehyde
diethyl acetate, 32

A2DE, 40

3

2-octanamine, 29

A2OA, 41

4

1-amino-2-propanol, 30

A2AP, 42

5

S-1-amino-2-propanol, 30S

R=

yield %

O
O

8

O

S-A2AP, 42-S

10

O

10

OH

OH

8

8
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A2-Aminoacetaldehyde dimethyl acetate (A2DM, 39), A2-aminoacetaldehyde
diethyl acetate (A2DE, 40), A2-aminooctane (A2AO, 41), A2-1-amino-2-propanol (A2AP,
42), and A2-S-1-amino-2-propanol (S-A2AP, 42-S) were synthesized in low yield (Table
2.4). The yields of PBRs with these amines are substantially lower than with the amines
reported above which successfully produced PBRs. This is likely due to the steric
hindrance caused by the acetal or the closer proximity of the hydroxyl groups in reactions
reported in Table 2.4; in addition, 2-octanamine is a 2° amine and all of the higher
yielding amines reacted are 1°.

2.7. Biomimetic Synthesis of the All-Trans-Retinal Dimer (43)
A new retinoid derivative, the all-trans-retinal (ATR) dimer (43), was found in
retinal pigment epithelial (RPE) cell fluorophores by Fishkin et al.5 The authors also
synthetically prepared the ATR dimer (43) by treating ATR (4) with 1 equivalent of
sodium hydride (NaH) in dry tetrahydrofuran (THF) using a method developed by
Verdegem.6

H
O

All-trans-retinal (ATR) dimer, 43
Chemical Formula: C40H 54O
Exact Mass: 550.4
Molecular Weight: 550.9

Figure 2.1 Structure of ATR dimer
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When we synthesized A2-ethanolamine (A2E, 1) via the biomimetic method
proposed by Parish et al,1 we found the ATR dimer (43) generated as a byproduct (Table
2.5). This marks the first time that the ATR dimer was observed as a result of a
biomimetic synthesis. Previously the only synthesis was observed as a result of using
harshly basic conditions. We show that the ATR dimer is also formed under mildly acidic
conditions.
We decided to analyze some of the other reactions listed in previous sections for the ATR
dimer side product (Table 2.5) and found that in 4 out of 5 reactions analyzed, that the
ATR dimer was indeed forming in low yield. The ATR dimer formed when ATR was
reacted with the alkyl amines, ethanolamine, propanolamine, NPD and EAE, but did not
form in the reaction with the aromatic tyramine (4-(2-aminoethyl)phenol).
The low yields of the ATR dimer in the biomimetic syntheses are likely due to
several factors; many of these are similar to those for PBRs. First, PBRs and ATR dimer
have many double bonds that easily isomerize. Second, they are highly sensitive to light;
ambient light exposure may have caused undesired photooxidation and decomposition,
even though all reactions and purifications were done in the dark. Photo-oxidation
products were continually observed by MS. Third, ATR and PBRs are unstable at room
temperature due to the reactivity of their polyene structures and the ATR aldehyde. Fourth,
some PBR and ATR dimer products may be lost in the process of chromatography⎯2 to
3 columns per reaction has been necessary to isolate them without impurities.
Additionally, most of the ATR reacts with the amine in the biomimetic reactions to
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produce PBRs, decreasing the possibility to afford dimer. Finally, the dimer is an unstable
aldehyde with adjacent bulky quaternary carbons, so they may not be stable.

Table 2.5 Biomimetic Synthesis of the All-Trans-Retinal Dimer
H
O

O
H

R

NH 2

O

AcOH
EtOH

+

O

N

R

PBRs

4

Entry

Amines

1

Ethanolamine, 5

2

Propanolamine, 24

3

Tyramine, 18

4

NPD, 26

N
H

5

EAE, 28

N
H

R=

OH

OH

OH

NH2

OH

ATR dimer, 43

yield %, PBRs

yield %, 43

18

37

13

3

15

0

0

4

0

4

Initially when we found the ATR dimer as a side–product in the synthesis of A2E,
we examined the MS of products formed during the preparation of PBRs, A2P and A2T.
A large peak at 551.4249 (Figure 2.2 A), belonging to the ATR dimer, was observed in the
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synthesis of A2P. When A2T was synthesized the MS did not show any peak related to
the ATR dimer (Figure 2.2 B).

Figure 2.2. MS of ATR dimer: (A) In preparation of A2P;
(B) In preparation of A2T.
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Scheme 2.3 Synthesis of ATR dimer and PBRs

To explain why the ATR dimer was formed in preparation of A2E and A2P but not
in A2T, we analyzed the biosynthetic pathway of the ATR dimer and A2E proposed by
Fishkin (Scheme 2.3).5 In Scheme 2.3 the general path is illustrated towards all PBRs
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(path C). Path C and path D are competitive and path C is favorable in the case of
preparation of A2E, A2P, and A2T.

H
O

HO

HN

( )n

Path D
OH

ATR dimer, 43

( )n

N

Pat

iminium ion 8c

enamine, 7c
hC

n= 1, 2

PBRs

H
O( )
n

N

OH

N

imnium ion 8d
intermediate, 8c'

Scheme 2.4 ATR Dimer vs PBR Formation

When ethanolamine and propanolamine were used in the reaction, the hydroxyl
group of iminium ion 8c (Scheme 2.4) can attack the carbon of the iminium ion to form
the 5 or 6-member-ring 8c'. Cyclic 8c' competes the progression of path C and
equilibrates back to the enamine 7c. This process makes the enamine more available to
proceed on path D which leads to the formation of the ATR dimer. The hydroxyl group in
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tyramine is much less likely to form a 9-membered cyclic intermediate, because the rigid
aromatic ring (iminium ion 8d) won’t allow the hydroxyl group to attack the carbon of
the iminium ion. Therefore, the iminium ion continues on path C unimpeded, resulting in
the formation solely of A2T without the ATR dimer side–product.
To test our proposed theory, we examined two other reactions for the existence of
the ATR dimer—the ATR reactions with NPD and EAE (Table 2.5). As indicated in
Scheme 2.3, the 5 or 6-member-ring intermediate likely forms in these reactions. The β
and γ nitrogens in NPD and EAE amines are more nucleophilic than that of the oxygens
in ethanolamine and propanolamine, and therefore form more stable 5 or 6 member ring
intermediates 8b. These intermediates impede intermediate 8b in Scheme 2.2 from
proceeding through an aza-6π-electrocyclization to continue on path C. Instead they
equilibrate back to intermediate 7b, which may then follow path D and generate ATR
dimer 43. This is why PBR products, A2NPD and A2EAE, were not observed in these
reactions and the ATR dimer was formed.

2.8 Summary and Conclusions
It has been demonstrated that the biomimetic synthetic method proposed by Parish
et al. 1 can be applied efficiently to the syntheses of PBRs other than A2E. This approach
can be further used to access ATR dimer, when ATR is reacted with alkyl amines that
have a nucleophilic atom which enables the formation of 5- or 6-membered ring
intermediates.
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The experimentation summarized in this thesis shows that the most important
aspect in synthesizing the reported PBRs is the amine’s structure. The β or γ nucleophilic
heteroatoms in the amines may direct the reaction mechanism along a pathway that does
not lead to PBRs or greatly decreases their yields, while increases the possibility of
forming the ATR dimer. The more nucleophilic the β or γ heteroatom, the more likely the
ATR dimer will be produced.
Finally, the syntheses of eight novel PBRs have been reported. Each of these can
now be investigated for their involvement in age-related macular degeneration or as
potential anticancer agents, by evaluating their reactivity, photochemistry, and
cytotoxicity.
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Chapter 3. Blue-Light Irradiation of Pyridinium Bisretinoids
3.1. Introduction
As described in Chapter 1, the fluorophore A2E (1, Figure 3.1), has been observed
to form a series of oxidation products when exposed to blue light (Figures 1.8 and 1.9).1-3
Jang et al.3 used UV-vis spectroscopy to follow the photo-oxidation and to identify which
retinoid chain on A2E was being chemically altered. The UV-vis absorption wavelength
of 337.4 nm corresponds to the shorter retinoid chain in A2E (1, λmax S, Figures 3.1 and
3.2) and of 440.4 nm corresponds to the longer chain (λmax L). Oxidation on either chain
of A2E leads to a hypochromic shift in the corresponding wavelength. In the UV-vis
spectrum of monofuran-A2E (13, Figure 1.9) and monoperoxy-A2E (16), only λmax S is
blue-shifted, while both λmax S and L are blue-shifted by about 40 nm in bisfuran-A2E
(14) and bisperoxy-A2E (15).
5
7

8
10

longer chain
λ max L

12

N

7'
5'

R = CH2OH, A2E, 1

14

8'

10' 12'

shorter chain
λmax S

R

R= CH2CH2OH, A2P, 34
R = CH2OCH2CH2OH, A2EE, 37
R = CH(OCH 3)2, A2DM, 39

Figure 3.1. Generic Pyridinium Bisretinoid Compounds
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Figure 3.2. UV-vis Spectrum of A2E
Because of the facile photo-oxidation of A2E, we proposed that other homologous
PBRs should exhibit similar photoreactivity. We irradiated a selection of PBRs with blue
light (Figure 3.3) and analyzed their photoproducts using electrospray ionization-mass
spectrometry (ESI-MS) and HPLC.

Figure 3.3. Photo-oxidation Experiment Setup
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3.2. Blue-Light Irradiation of A2-Propanolamine
A2-Propanolamine (A2P, 34, Figure 3.1) was exposed to blue light (442 ±10 nm)
for five hours. Samples were taken every hour starting immediately prior to irradiation (0
hours) and analyzed by ESI-MS and HPLC. The MS results for A2P irradiation at zero,
one, four, and five hours are shown in Figure 3.4.
Prior to irradiation (0 hours), the MS shows a single peak with a mass-to-charge
ratio (m/z) of 606, corresponding to the unoxidized pyridinium bisretinoid, A2P (34).
After one hour of irradiation, seven oxidation products appeared, each in increments of
+16 from the last, starting at the peak with an m/z of 622. This peak is consistent with the
addition of one oxygen atom to A2P. Peaks with m/z 638, 654, 670, 686, 702, and 718
likely represent the addition of two, three, four, five, six, and seven oxygen atoms on
either or both of the two retinoid arms of A2P. The highest intensity peak after one hour
of irradiation has an m/z of 638 (bisoxygenated A2P), the next highest has an m/z of 654
(trioxygenated A2P), and the next has an m/z of 622 (mono-oxygenated A2P). The MS
results of A2P blue-light irradiation at two and three hours are similar to those observed
after one hour of irradiation.
The longer that A2P is exposed to blue light the more A2P deceases in
concentration and its oxidation products increase. After four hours of irradiation the MS
shows almost complete consumption of A2P, while the purported mono-, bis-, and
tri-oxygenated A2P compounds (m/z 622, 638, and 654) have all increased in
concentration.
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Figure 3.4. ESI-MS Spectra of A2P Blue-Light Irradiation
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After five hours of irradiation, no A2P (m/z 606) was observed and only a trace
amount of bisoxygenated A2P (m/z 638) showed up on the MS. In summary, the ESI-MS
results show that A2P formed seven oxidation products during irradiation (m/z 622, 638,
654, 679, 686, 702 and 718), which fluctuate in concentration depending on the length of
irradiation.
Like A2E, A2P has one shorter and one longer retinoid chain attached to its
pyridinium ring (R = CH2CH2OH, A2P, 34, Figure 3.1). Jang et al.3 found that A2E’s
short retinoid chain is more readily oxidized than its longer chain. We examined which
A2P chain was more reactive using HPLC analysis.
The irradiation process of A2P was analyzed by comparing its HPLC data before
irradiation (0 hours, Figure 3.5) and after one hour of irradiation (1 hour). The HPLC
data after 2-5 hours of irradiation did not show any significant A2P or oxidation peaks,
which suggests that the A2P was converted into a complex mixture of products after 2
hours; only the MS was sensitive enough to pick up signals from these products.
Prior to irradiation, HPLC reveals a single peak with a retention time of 9.60
minutes. After one hour of exposure to blue light, additional peaks appeared. The UV-vis
profile of the peaks labeled B reveals an absorbance at 227.4 nm. These peaks could be
solvent front, although they are not present before irradiation (0 hours). The peaks are
likely some type of A2P degradation products, but from UV-vis analysis they do not
appear to be oxidized A2P.
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Figure 3.5. HPLC Results of A2P Blue-Light Irradiation
The UV-vis spectrum of peak C was also examined and appears to be a
mono-oxidation product of A2P (44, 45, or 46, R = CH2CH2OH, Figure 3.6). Comparing
53

the UV-vis of peak C to that of peak A, the initial oxidation of A2P appears to occur on
the longer retinoid chain. A blue shift of 20 nm from 438 to 418 nm occurs after
irradiation, which suggests a loss of conjugation on the longer retinoid chain. No
significant change is observed in λmax S, which moved from 341 to 337 nm. These results
suggest that A2P’s longer retinoid chain is more photoreactive than its shorter chain.
The oxidation product mixtures of A2E and A2P are complicated. On A2E, the
short retinoid chain is oxidized first (13 and 16, Figure 1.9), and on A2P, which simply
has one additional methylene, the long retinoid chain is oxidized first (44–46, R =
CH2CH2OH, Figure 3.6). Additionally, the maximum number of oxygen atoms added to
A2E is nine when it is photo-oxidized, while we only observed the addition of seven
oxygen atoms to A2P.
In the oxidation of A2P, the HPLC results appear to conflict with the ESI-MS
results, because HPLC reveals more mono-oxidation and MS reveals more bisoxidation.
Because MS is not a good tool for quantification, it is possible that the bisoxidation
product simply flies better in the MS than the mono-oxidation product.
The ESI-MS and HPLC data collected in A2E’s photo-oxidation studies,1-3 as
well as for A2P’s photo-oxidation, were all taken into account when assigning structures
for A2P’s possible oxidation products. Some of the possible A2P oxidation products are
shown in Figure 3.6.
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Figure 3.6. Possible Photo-oxidation Products of PBRs
R= CH2CH2OH, PBR=A2P, 34
R = CH2OCH2CH2OH, PBR=A2EE, 37
R = CH(OCH3) 2, PBR=A2DM, 39

A2P’s oxidation likely starts with the formation of the epoxides (44, 46, and 47)
and then rearranges to the furanoxides (45 and 48). The MS peak with an m/z of 670 is
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associated with the addition four oxygen atoms to A2P. Because tetraoxygenated A2E is
reported to be the bisperoxy A2E (15, Figure 1.9),3 the proposed structure for
tetraoxygenated A2P is likewise the bisperoxy compound (49, R = CH2CH2OH, Figure
3.6). The oxidation products of these PBRs are difficult to deconvolute, and we are only
beginning to gain small insights into their structures.

3.3. Blue-Light Irradiation of A2-2-(2-Aminoethoxy)ethanol
Because A2-2-(2-aminoethoxy)ethanol (A2EE, 37, Figure 3.1) is similar in
structure to A2E (1), but with an additional hydroxyethyl group, we proposed that A2EE
might produce similar photo-oxidation products to A2E (1) and A2P (34).
Photo-oxidation of A2EE (37) was performed using the same methods described for A2P
(34, Section 3.2). Aliquots were taken every hour for five hours, and the reaction was
monitored by ESI-MS and HPLC.
The ESI-MS results prior to irradiation of A2EE (0 hours) reveal a single peak
with an m/z of 636, corresponding to pure A2EE. At one hour, three new peaks with m/z
652, 668 and 684 appear, suggestive of A2EE oxidation products containing one to three
new oxygen atoms (Figure 3.7). The ratio of A2EE to the three new MS oxidation peaks
after one, two, and three hours is similar to that shown in Figure 3.7 after one hour of
irradiation; A2EE is still clearly the predominant MS peak.
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Figure 3.7. ESI-MS of A2EE Blue-Light Irradiation
After four hours of blue-light irradiation, a fourth, smaller oxidation peak with an
m/z of 700 is observed, suggestive of tetraoxygenated A2EE. The ratio of bis- to
mono-oxygenated A2EE also increases. Finally, at five hours, the ratios of oxidation
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peaks to the parent A2EE peak changes even more significantly. At this point the
mono-oxidation peak with an m/z of 652 is closer in intensity to the A2EE peak with an
m/z of 636 compared to previous hours. Additionally, a new oxidation peak (m/z 716)
appeared, corresponding to the addition of five oxygen atoms to A2EE.
Throughout the five hours of blue-light irradiation, the peak with an m/z of 636,
corresponding to A2EE, was the most abundant. The next largest peak corresponded to
bisoxygenated A2EE (m/z 652). The peaks corresponding to higher oxygenated products
(tri-, tetra-, and penta-) decreased in intensity respectively as the number of oxygen
atoms increased. The longer A2EE was exposed to blue light, however, the more its
associated peak decreased in intensity as the oxidation product peaks increased. Overall,
the turnover from the parent A2EE to its oxidation products did not occur as readily as it
did for A2E (with nine oxidation products) and A2P (with seven oxidation products).
HPLC was also used to monitor the oxidation of A2EE. Figure 3.8 shows a
chromatogram before blue-light irradiation, as well as after four hours of irradiation. The
data after one, two, and three hours is not shown, because no significant oxidation
products were observed until four hours. Likewise, the data after five hours of irradiation
is not shown, because it is similar to that observed after four hours.
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Figure 3.8. HPLC Results of A2EE Blue-Light Irradiation
Before irradiation, a single peak (A, 0 hours), corresponding to A2EE, has a
UV-vis spectrum with two wavelength maxima at 337 and 441 nm. In Figure 3.1, λmax S
corresponds to 337 nm and λmax L corresponds to 441 nm for A2EE (37), R =
CH2OCH2CH2OH.
After four hours of irradiation, approximately 75 % of the A2EE still remained
and new peaks appeared (Figure 3.8, 4 hours). The UV-vis spectrum of peak B, the
largest of the new peaks, was compared to that of A2EE. We observe that only λmax L of
peak B is significantly blue shifted (from 441 nm to 417 nm). This suggests that peak B
might be mono-oxygenated A2EE (m/z of 652), which is also the second most intense
peak observed on MS at 4 hours (Figure 3.7). Based on the UV-vis data, A2EE appears to
be oxidized first on its longer retinoid chain (44, 45, or 46, R = CH2OCH2CH2OH, Figure
3.6).
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In summary, A2EE does not appear to be as labile to photo-oxidation as A2E and
A2P. A2EE forms a total of 5 oxidation products after five hours. Its longer retinoid chain
appears to more readily photo-oxidize than the shorter one.

3.4. Blue Light Irradiation of A2-Aminoacetaldehydedimethylacetate
Photo-oxidation of A2-aminoacetaldehydedimethylacetate (A2DM, 39, Figure 3.1)
was performed using the same methods described for A2P (34, Section 3.2). Figure 3.10
shows the ESI-MS results of photoirradiation of A2DM (39) at one and three hours.
Before irradiation a single peak is observed with an m/z of 636, corresponding to A2DM.
After one hour, six new peaks were formed starting from m/z 652 and increasing in
increments of +16. The most abundant peak at 1 hour corresponds to mono-oxygenated
A2DM. Peaks at m/z 668, 684, 700, 716, and 732 correspond to the addition of two, three,
four five and six oxygen atoms to A2DM. The MS results at two hours are similar to that
at one hour except that the peak with an m/z of 668 (bisoxygenated-A2DM) is the largest
one.
At 3 hours A2DM’s peak (m/z 636) was small compared to its oxidation product
peaks, and the bisoxygenated-A2EE peak (m/z 668) was still at the highest intensity.
After 4 hours, all of the A2DM was consumed and only its oxidation products were
observed.

60

Figure 3.9. ESI-MS of A2DM Blue-Light Irradiation
HPLC analysis was performed as described in previous sections. A2DM was
analyzed before blue-light irradiation and after one and two hours of irradiation. The
corresponding HPLC chromatograms and UV-vis spectra are shown in Figure 3.10. The
HPLC data at 0 hours show all-trans A2DM as the major peak (B), as confirmed by
UV-vis, as well as 3 additional peaks. Peaks A and C appear to be cis-isomers of A2DM,
and peak D is all-trans-retinal.
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Figure 3.10. HPLC Results of A2DM Blue-Light Irradiation
After one hour, irradiation peaks E, F, G, and H appeared and no obvious A2DM
peak was observed. MS data at one hour still shows the presence of A2DM, so it is likely
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in quantities that are undetectable by HPLC. Based on the UV-vis data, peak E appears to
be trioxidized A2DM, with more loss of conjugation on λmax S, than on λmax L (Figure
3.l). Peak F appears to be a bisoxidized compound, such as one of the compounds
suggested in Figure 3.6. Peak G corresponds with an isomer of all-trans A2DM, and
Peak H is solvent front or otherwise degraded A2DM.
After 2 hours, no A2DM peak was observed, which again likely has to do with
the trace quantities that remain and are only detectable by MS. No A2DM or oxidation
products were detected by HPLC after three hours. MS detected only small quantities of
these compounds. A2DM appears to be more readily oxidized than A2P and A2EE, with
even the trioxygenated compound observed by HPLC/UV-vis. Although A2DM can only
form six oxidation products compared to the seven products observed for A2P, the
oxidation of A2DM happens at a faster rate.

3.5. Summary and Conclusions
The blue-light irradiation of three novel pyridium bisretinoids has been studied
using ESI-MS and HPLC chromatography. The results demonstrate that A2P, A2EE, and
A2DM are photo-oxidized in the presence of blue-light. Analysis of the results by MS
and HPLC revealed that epoxide, furanoxide, and peroxide oxidation products are
forming—similar to the types of oxidation products formed by irradiation of A2E. A
comparison of the UV-vis spectra suggest that the initial position of oxidation varies, as
well as the rate of oxidation, and the number of total oxygen atoms added to each
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molecule. The data still show that A2P and A2DM are far more efficiently oxidized under
blue light than A2EE.
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Chapter 4. Photoactivated Cytotoxicity of Pyridinium Bisretinoids
4.1. Introduction
The photoreactivity of A2E is illustrated in Chapter 1.1-6 In addition to the
cytotoxicity of photoirradiated A2E in RPE cells, results obtained in our laboratory
indicate that A2E demonstrates photoinduced cytotoxicity in a selection of cancer cell
lines.7 Since A2P and A2EE (Chapter 2), which are structurally similar to A2E, were also
photo-oxidized when irradiated with blue light (Chapter 3), we hypothesized that these
compounds would undergo phototriggered cytotoxicity in HL-60 (human promyelocytic
leukemia) cells.
To test this hypothesis, A2P and A2EE were incubated with HL-60 cells in
24-well plates for 24 hours and then irradiated using a 476 mW/cm2 fiber optic source
with a 442 nm (blue) filter (Figure 4.1). A range of drug concentrations and irradiation
times were tested in order to find the optimal conditions, where the maximum number of
irradiated cells 1 loaded with PBRs were killed compared to the controls. After irradiation
and further incubation, we assayed the number of viable cells and compared these with
control samples, which were not loaded with a PBR or not irradiated. In each experiment,
either the trypan blue cell count (TBCC) procedure or the 3-(4,5-dimethyl-2-thiazolyl)-25-diphenyl-2H-tetrazolium bromide (MTT) assay was used to evaluate the response of
the HL-60 cells to A2P and A2EE.

1

Cells in this chapter refers to HL-60 cells, unless otherwise stated.
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Trypan blue is the most common stain used to distinguish viable cells from
nonviable cells. Only nonviable cells absorb the dye, appear blue, and may also be
asymmetrical. The viable cells do not absorb the dye, appear refractile, and remain
round.

Figure 4.1. Irradiation Setup

The MTT assay is a standard colorimetric assay for measuring cellular proliferation.
The yellow MTT is reduced to purple formazan in the mitochondria of living cells. This
reduction only takes place when mitochondrial reductase enzymes are active, and therefore
conversion can be directly related to the number of viable cells.
In column graphs showing the results of the cell assays, the heights of the
columns are proportional to the cell viability. The red columns represent the cell viability
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without any light exposure and the blue ones indicate the cell viability after blue light
irradiation. The experiments were performed two or more times. Standard deviations
were calculated and shown with error bars. All p-values in this chapter are calculated
using the two tail type three t-test. If the reported p-values are below 0.05, then the two
sets of experiments being compared are considered statistically significant.

4.2. Photoactivated Cytotoxicity of A2-Propanolamine in HL-60 Cells
4.2.1. Optimization of A2P concentration. A2P (5 and 10 μM) was incubated
with HL-60 cells for 24 hours and irradiated with blue light for 45 minutes. Media
control experiments were performed with and without irradiation and with and without
DMSO. Figure 4.2 illustrates the cell viability after incubation and irradiation as
determined by the TBCC procedure.
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Figure 4.2. A2P incubated in HL-60 cells with 45 minute blue-light irradiation.
The control experiments performed with and without irradiation and with and
without DMSO showed no statistically significant differences (p > 0.5), which means
that light exposure and DMSO alone did not cause cell death. In addition, no statistically
significant differences were observed when the media and DMSO controls were directly
compared (p > 0.1) and when the 5 and 10 μM A2P experiments were compared to the
media controls (p > 0.1 and 0.05, respectively). When 5 μM A2P was incubated with
HL-60 cells with and without blue light irradiation no significant cell death was observed
(p > 0.5). The irradiation of cells incubated with 10 μM A2P resulted in 80 % cell death
compared to the nonirradiated samples of 10 μM A2P (p = 0.0001). The data show that
45-minute blue-light irradiation of 10 μM A2P effectively kills HL-60 cells.
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4.2.2. Optimization of A2P irradiation time. To determine the optimum blue-light
irradiation time, we performed the celluar assays described above on 10 μM A2P and
irradiated for 30 and 40 minutes. This time we used the MTT assay to determine cell
viability. No statistically significant differences were observed when A2P was irradiated
for 30 minutes (p > 0.1); therefore, only the data for the 40 minute irradiation is shown in
Figure 4.3.
The analysis of the controls with and without irradiation, with and without
DMSO, and directly comparing the media and DMSO controls showed no statistically
significant differences (p > 0.5). Furthermore, no statistically significant differences were
observed when 10 μM A2P experiments were compared to the media controls (p > 0.05).
The irradiation of cells with 10 μM A2P resulted in >80 % cell death compared to the
nonirradiated samples of 10 μM A2P (p < 0.01). The data show that 40-minute blue-light
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irradiation of 10 μM A2P effectively kills HL-60 cells.
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Figure 4.3. A2P incubated in HL-60 cells with 40 minute blue-light irradiation.

4.2.3. Discussion. The results reported in the preceding sections reveal that
blue-light irradiated A2P alone is responsible for the observed HL-60 cell death. Of the
two A2P concentrations compared, only the higher 10 μM concentration caused
significant cell death. The longer the 10 μM A2P was exposed to blue light, the more
statistically significant the cell death observed; the optimal irradiation time was 45
minutes. Irradiation over 45 minutes began to damage the controls (data not shown). In
the future, experiments will continue to be optimized by changing the light source,
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intensity, and wavelength to determine whether lower concentrations of irradiated A2P
can also cause significant cell death.

4.3. Photoactivated Cytotoxicity of A2-2(2-Aminoethoxy)ethanol in HL-60 Cells
The same cell culture care and assay procedures as described in the preceding
sections were used when A2-2(2-aminoethoxy)ethanol was incubated in HL-60 cells with
and without blue light. The MTT assay was performed to determine cell viability 24
hours after irradiation.
4.3.1.Optimization of A2EE concentration. In order to determine the optimum
concentration of A2EE for our cellular assays, we incubated 1–13 μM A2EE without
blue-light irradiation in HL-60 cells. Results from the MTT assay showed that 5 and 7
μM A2EE were the best concentrations to run the blue-light irradiation assays. At higher
and lower concentrations A2EE incubated in cells without irradiation begins to cause cell
death. We are uncertain why lower concentrations cause cell death, but nevertheless
moved forward with 5 and 7 μM A2EE.
A2EE (5 μM) was incubated with HL-60 cells for 24 hours and irradiated with
blue light for 30 minutes. Media control experiments were performed with and without
irradiation and with and without DMSO. No statistically significant differences were
observed in any of the control experiments or when 5 μM A2EE was irradiated for 30
minutes (p > 0.5); therefore, only the experimental data for the irradiation of 7 μM A2EE
is shown in Figure 4.4.
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The analysis of the controls with and without irradiation, with and without DMSO,
and directly comparing the media and DMSO controls showed no statistically significant
differences (p > 0.5, 0.1, and 0.05, respectively). Furthermore, no statistically significant
differences were observed when 7 μM A2EE experiments were compared to the media
controls (p > 0.1). The irradiation of cells with 7 μM A2EE resulted in 20 % cell death
compared to the nonirradiated samples of 7 μM A2EE (p < 0.05). The data show that
30-minute blue-light irradiation of 7 μM A2EE kills HL-60 cells.
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Figure 4.4. A2EE incubated in HL-60 cells with 30 minute blue-light irradiation.
4.3.2. Optimization of A2EE irradiation time. To determine the optimum
blue-light irradiation time, we performed the cellular assays described above on 7 μM
A2EE and irradiated for 40, 45, and 50 minutes. Results from the MTT assay showed
that no statistically significant differences were observed when A2EE was irradiated for
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40 or 45 minutes (p > 0.1 and 0.5, respectively); therefore, only the data for the
50-minute irradiation is shown in Figure 4.5.
The control experiments performed with and without 50- minute irradiation and
with and without DMSO showed no statistically significant differences (p > 0.1), which
means that light exposure and DMSO alone did not cause cell death. In addition, no
statistically significant differences were observed when the media and DMSO controls
were directly compared (p > 0.5) and when the 7 μM A2EE experiments were compared
to the media controls (p > 0.1). The irradiation of cells incubated with 7 μM A2EE
resulted in 50 % cell death compared to the nonirradiated samples of 7 μM A2EE (p <
0.05). The data show that 50-minute blue-light irradiation of 7 μM A2EE effectively kills
HL-60 cells.
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Figure 4.5. A2EE incubated in HL-60 cells with 50 minute blue-light irradiation.
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4.3.3. Discussion. The results reported in the preceding sections reveal that
blue-light irradiated A2EE causes HL-60 cell death. Of the two A2EE concentrations
compared, only the higher 7 μM concentration caused significant cell death. When 7 μM
A2EE was irradiated for 30 and 50 minutes, statistically significant cell death was
observed. Blue-light exposure over 50 minutes began to damage the controls (data not
shown).
In these cellular assays anomalous behavior was observed in two areas. First, the
control concentration experiments without irradiation revealed cell death at low
concentrations of A2EE (1–3 μM), while higher concentrations did not result in cell
death (5–9 μM). Second, irradiation for 40 and 45 minutes did not cause significant cell
death, but 30 minute irradiation did result in cell death. These anomalous results suggest
a need to run more experiments to confirm current A2EE irradiation results. After
confirming these results, we will continue to optimize the experiments as described in
section 4.2.3.

4.4. Summary and Conclusions
Two PBR compounds, A2P and A2EE were incubated and irradiated in HL-60
cells. Under the right conditions, both caused cell death after irradiation. The exact
mechanism of HL-60 cell death has not yet been studied, but based on A2E
photoirradiation studies in RPE cells,1,2,4 the HL-60 cells may also be undergoing
apoptosis.
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A2P appears to be more readily photo-oxidized than A2EE. The photo-oxidation
results in Chapter 3 support this claim, because A2EE takes longer to form oxidation
products than does A2P; only 20 % of A2EE is oxidized in the first hour.
Although there is still room for optimization, the results from both the A2P and
A2EE cellular assays are promising. These compounds exhibit phototriggered
cytotoxicity. Future studies involve the attachment of folic acid to these compounds so
that they can be specifically targeted to cancer cells. If successful, A2P, A2EE, and other
pyridinium bisretinoid compounds may be developed into a targeted and triggered drug
delivery system for cancer.

4.5. References
1. Sparrow, J. R.; Nakanishi, K.; Parish, C. A. Invest. Ophthalmol. Vis. Sci. 2000, 41,
1981–1989.
2. Sparrow, J. R.; Cai, B. Invest. Ophthalmol. Vis. Sci. 2001, 42, 1356–1362.
3. Sparrow, J. R.; Zhou, J.; Ben-Shabat, S.; Vollmer-Snarr, H. R.; Itagaki, Y.; Nakanishi,
K. Invest. Ophthalmol. Vis. Sci. 2002, 43, 1222–1227.
4. Sparrow, J. R.; Vollmer-Snarr, H. R.; Zhou, J.; Jang, Y. P.; Jockusch, S.; Itagaki, Y.;
Nakanishi, K. J. Biol. Chem. 2003, 278, 18207–18213.
5. Dillon, J.; Wang, Z.; Avalle, L. B.; Gaillard, E. R. Exp. Eye Res. 2004, 79, 537-542.
6. Jang, Y. P.; Matsuda, H.; Itagaki, Y.; Nakanishi, K.; Sparrow, J. R. J. Biol. Chem. 2005,
280, 39732–39739.
75

7. Vollmer-Snarr laboratory, unpublished results.

76

Chapter 5. Experimental
5.1. General Experimental
All reactions and column purifications were conducted in the dark at room
temperature. All solvents and reagents were obtained from Fluka or Aldrich, unless
otherwise noted, and used as purchased. Silica gel powder (40-63 μm gel) for column
chromatography was purchased from Sorbent Technologies. Reactions were monitored
by TLC and/or ESI-MS prior to work-up. TLC was performed using aluminum backed
200 μm plates from Sorbent Technologies. TLC plates were visualized using UV254 light.
Solvents were removed in vacuo on a Büchi RE 47 rotary evaporator combined with a
water condenser, using a Büchi 461 water bath combined with a water pump. HPLC and
UV-vis spectra were obtained from a Waters 600 HPLC system equipped with a Waters
2998 photodiode array detector and with a Cosmosil packed column 5C18-P-MS 4.6 x
250 mm or a Phenomenex Synergi Max 250 x 4 mm column. HPLC grade H2O spiked
with 0.1% trifluoracetic acid (TFA), acetonitrile (ACN), and methanol were used as
eluants. MS data were obtained on an Agilent Technologies Multimode Electrospray
APCI mass spectrometer running in ES+ APCI+ mode. All 1H-NMR spectra were
obtained from a Varian Unity Inova 500 MHz spectrometer using tetramethylsilane
(TMS) (0.00 ppm) and chloroform (7.26 ppm) as internal standards. Signals are reported
as s (singlet), d (doublet), t (triplet), m (multiplet), dd (doublet of doublets), and bs
(broad singlet). Coupling constants are reported in hertz (Hz). 13C-NMR spectra were
obtained with a 125 MHz Varian NMR using TMS (0.00 ppm) and chloroform (7.26 ppm)
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as internal standards. 1H-1H COSY and 1H -13C HETCOR correlations are reported as
follows: w (weak), m (medium), s (strong).
An Edmund Optics’ Mille Luce™ Fiber Optic Illuminator M1000 with a 442 nm
(blue) filter is used to irradiate cells. The intensity of the light reaching the samples is ~
476 mW/cm2.
HL-60, human promyelocytic leukemia cells are obtained from Dr. Kim O′Neill,
Department of Microbiology and Molecular Biology Brigham Young University. They
are grown in RPMI supplemented with 10% fetal bovine serum. The cells are kept in a
humidified 5% CO2 incubator at 37° C and stock cultures are maintained in our
laboratory. Growth curves for the HL-60 cells were completed using the trypan blue
exclusion protocol described below. Trypan Blue solution was purchased from Sigma.
Absorbance values in MTT cell proliferation assays were obtained from a VMax kinetic
microplate reader.

5.2. Synthesis of Starting materials

O

All-Trans-Retinal (4)

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8tetraenal

All-Trans-Retinal (4): According to the procedure by Sollaolie et al.,2 MnO2 (2.0
g, 23.2 mmol) was added to the solution of all-trans-retinol (3.3 g, 11.6 mmol). The
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solution was stirred for 3 h, and the mixture was filtered and concentrated in vacuo to
give crude all-trans-retinal. The crude material was purified by silica gel column
chromatography (silica, eluted with 10:90 EtOAc:Hexane) to yield yellow crystals (2.6 g,
9.3 mmol, 80%) of all-trans-retinal. TLC and 1H-NMR were used to confirm the
structure and compared to the literature values.
OH

All-Trans-Retinol (50)

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8tetraen-1-ol

All-Trans-Retinol (51): According to the procedure by Duffy et al.,1 vitamin A
propionate (5.1 g, 15.5 mol) and K2CO3 (2.4 g, 17.1 mmol) were dissolved in THF (4.0
ml) and methanol (25.0 ml). The solution was stirred in the dark at room temperature for
2 h, and the reaction progress was monitored by TLC. Diethyl ether and hexane (2:1)
were added, and the mixture was agitated, filtered, and concentrated in vacuo to give
crude all-trans-retinol. The crude product was purified by silica gel column
chromatography (silica, eluted with 5:95 EtOAc:Hexane) to give pure all-trans-retinol
(3.8 g, 11.6 mmol, 85%) as a yellow oil. TLC and 1H-NMR were used to confirm the
structure and compared to the literature values.
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5.3 Synthesis of Bisretinoids
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A2T (33)

2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-enyl)octa-1,3,5,7tetraenyl)-1-(4-hydroxyphenethyl)-4-((1E,3E,5E)-4-methyl-6-(2,6,6trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl)pyridinium

A2T (33): All-trans-retinal (200.0 mg, 0.7 mmol), tyramine (42.6 mg, 0.3 mmol),
and acetic acid (18.4 μl, 0.3 mmol) were stirred in ethanol (25.0 ml) at room temperature
in the dark for 48 h. The solvent was removed in vacuo, and the residue was purified 2–3
times by column chromatography (silica, eluted with CH2Cl2 first, then with 10:90:0.01
MeOH:CH2Cl2:CH3COOH) to afford A2T (31.1 mg, 15 %) as a dark-red oil. HRMS
(ESI+) calcd 668.4826 for [C48H62NO]+, found 668.4819; UV-vis λmax 339.8 nm, 442.08
nm; 1H-NMR (CDCl3, 500 MHz) δ 8.80 (bs, 1H), 7.64-7.69 (m, 2H), 7.27 (d, J =2 Hz,
1H), 6.94 (t, J = 12.5 Hz, 1H), 6.79 (bs, 2H), 6.64 (d, J = 7, 2H), 6.52 (bs, 1H), 6.48 (bs,
1H), 6.44 (d, J = 15 Hz, 1H), 6.38 (bs, 1H), 6.34 (d, J = 8 Hz, 1H), 6.27 (dd, J = 16.5, 9
Hz, 1H), 6.20 (bs, 1H), 6.17 (d, J = 6 Hz, 1H), 6.07 (bs, 1H), 4.59 (bs, 2H), 2.96 (bs, 2H),
2.12 (bs, 3H), 2.02-2.04 (m, 7H), 1.97 (s, 3H), 1.74 (bs, 6H), 1.62-1.63 (m, 4H),
1.48-1.49 (m, 4H), 1.04-1.05(m, 6H); 13C-NMR (CDCl3, 125 MHz) δ 178.18, 158.71,
152.42, 150.96, 146.97, 146.38, 140.71, 138.07, 137.85, 137.77, 137.39, 136.86, 133.67,
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132.58, 131.99, 131.39, 130.60, 129.88, 129.40, 128.97, 125.21, 124.41, 120.86, 118.72,
116.84, 58.50, 39.84, 36.01, 34.54, 34.51, 33.52, 33.38, 29.95, 29.24, 25.09, 22.11, 22.06,
19.44, 19.63, 15.10, 13.61, 13.23; DEPT (CDCl3, 125 Hz): 9-CH3, 8- CH2, 18- CH,
13-C; 1H-1H COSY (CDCl3, 500Hz): 8.80/7.66-7.69 (w, H-e/H-d), 7.66-7.69/7.64 (s,
H-d-H-f), 6.79/6.64 (s, H-c1,c2/H- d1,d2), 4.59/2.96 (w, H-a/H-b), 2.04/1.62-1.63 (m,
H-4,4'/H-3,3'), 1.62-1.63/1.48-1.49 (s, H-3,3'/ H-2,2'); 1H -13C HETCOR (CDCl3):
8.80/146.38 (w, H-e/C-e), 7.64-7.69/138.07 (w, H-d, f/C-d, f), 6.64/131.39 (w, H-c3,
c4/C-c3, c4), 4.59/58.51 (H-a/C-a), 2.96/36.01 (w, H-b/C-b), 1.95-1.97/33.38-33.52 (m,
H-9a, 9'a/C-9a, 9'a), 1.04/29.24 (s, H-1a, 1b, 1'a,1'b/C-1a, 1b, 1'a,1'b), 1.74/22.07-22.11
(w, H-5a, 5'a/C5a, 5'a), 1.48/19.36-19.44 (H-2, 2'/C2, 2').
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A2P (34)

2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-enyl)octa-1,3,5,7tetraenyl)-1-(3-hydroxypropyl)-4-((1E,3E,5E)-4-methyl-6-(2,6,6trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl)pyridinium

A2P (34): All-trans-retinal (100.0 mg, 0.4 mmol), 3-amino-1-propanol (11.7 mg,
0.2 mmol), and acetic acid (9.2 μl, 0.2 mmol) were stirred in ethanol (10.0 ml) at room
temperature in the dark for 48 h. The solvent was removed in vacuo and the residue was
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purified 2–3 times by column chromatography (silica, eluted with CH2Cl2 first, then with
15:85:0.01 MeOH:CH2Cl2:CH3COOH) to afford A2P (12.2 mg, 13 %) as a dark-red oil.
HRMS (ESI+) calculated (calcd) for [C43H60NO]+ 606.4669, found m/z 606.4664;
UV-vis λmax 337.4 nm, 438.0 nm; 1H-NMR (CDCl3, 500 MHz) δ 9.69 (bs, 1H), 7.92 (bs,
1H), 7.73 (m, 1H), 7.33 (bs, 1H), 7.00 (dd, J = 14.8, 12 Hz, 1H), 6.43-6.55 (m, 4H),
6.17-6.37(m, 5H), 4.75 (bs, 2H), 3.72 (bs, 2H), 2.15 (s, 3H), 2.09 (s, 3H), 2.04-2.06 (m,
9H), 1.75 (s, 3H), 1.74 (s, 3H), 1.63-1.64 (m, 4H), 1.48-1.51 (m, 4H), 1.06 (s, 6H), 1.05
(s, 6H); 13C-NMR (CDCl3, 125 MHz) δ 177.21, 152.67, 150.60, 147.78, 147.29, 146.60,
141.05, 138.18, 137.79, 137.27, 136.76, 134.38, 133.67, 132.82, 132.05, 131.689, 130.71,
129.77, 129.19, 128.81, 125.49, 125.06, 120.88, 118.29, 57.49, 54.82, 39.84, 34.54,
33.52, 33.38, 32.92, 29.21, 26.203, 23.92, 22.06, 19.42, 19.36, 15.24, 13.59, 13.23;
1

H-1H COSY (CDCl3, 500Hz): 9.70/7.92 (m, H-e/H-d), 7.71-7.76/6.52 (s, H-f/H-12'),

7.71-7.76/6.33-6.37 (s, H-f/H-14), 6.52/7.00 (s, H-12'/H-10'), 7.00/6.20-6.22 (s,
H-10'/H-11') 4.75/2.05 (s, H-a/H-b), 3.72/2.05 (H-c/H-b); 1H -13C HETCOR (CDCl3):
9.70/147.78 (w, H-e/C-e), 7.71-7.76/138.18 (m, H-f/C-f), 6.33-6.37/136.76(s,
H-14/C-14), 6.52/133.67 (m, H-12'/C-12'), 7.00/131.69 (m, H-10'/C10'),
6.20-6.22/129.19 (s, H-11'/C-11'), 4.75/54.82 (w, H-a/C-a), 3.72/57.49 (m, H-c/C-c),
2.10/33.52 (m, H-9'/C-9'), 2.04/33.38 (m, H-9/C-9), 2.06/32.92 (m, H-4, 4'/C-4, 4'),
2.05/23.92 (m, H-b/C-b), 1.74-1.75/22.06 (s, H-5, 5'/C5, 5'), 1.63-1.64/19.36-19.42 (s,
H-3, 3'/C-3, 3'), 1.05/29.21 (s, H-1, 1'/C1, 1').
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A2EE (37)

2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-enyl)octa-1,3,5,7tetraenyl)-1-(2-(2-hydroxyethoxy)ethyl)-4-((1E,3E,5E)-4-methyl-6-(2,6,6trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl)pyridinium

A2EE (37): All-trans-retinal (200.0 mg, 0.7 mmol), 2-(2-aminoethoxy) ethanol
(32.5 mg, 0.3 mmol), and acetic acid (18.4 μl, 0.3 mmol) were stirred in ethanol (25.0 ml)
at room temperature in the dark for 48 h. The solvent was removed in vacuo and the
residue was purified 2–3 times by column chromatography (silica, eluted with CH2Cl2
first, then with 20:80:0.01 MeOH:CH2Cl2:CH3COOH) to afford A2EE (32.2 mg, 16 %)
as a dark-red oil. HRMS (ESI+) calcd 636.4775 for [C44H62NO2]+, found 636.4823;
UV-vis λmax 337.4 nm, 441.60 nm; 1H-NMR (CDCl3, 500 MHz) δ 9.70 (bs, 1H), 7.91
(bs, 1H), 6.98 (dd, J = 14.75, 11 Hz, 1H), 7.31 (bs, 1H), 6.98 (dd, J = 15, 11 Hz, 1H),
6.54 (bs, 1H), 6.49 (d, J = 14.5 Hz, 1H), 6.44 (d, J = 5 Hz, 1H), 6.34-6.37 (m, 1H),
6.28-6.32 (m, 1H), 6.16-6.25 (m, 4H), 4.87 (bs, 2H), 3.94 (bs, 2H), 3.74 (d, J = 8 Hz, 4H),
2.14 (bs, 3H), 2.08 (bs, 3H), 2.03-2.06 (m, 7H), 1.74 (d, J = 6 Hz, 6H), 1.62-1.65 (m, 4H),
1.48-1.50 (m, 4H), 1.05 (d, J = 5.5 Hz, 6H); 13C-NMR (CDCl3, 125 MHz) δ 177.282,
152.76, 150.76, 148.48, 147.03, 146.51, 140.93, 138.09, 137.85, 137.78, 137.27, 137.05,
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136.76, 133.60, 132.78, 132.04, 131.51, 130.10, 129.69, 129.17, 128.81, 125.26, 125.14,
120.52, 118.59,73.44, 68.62, 61.60, 56.19, 39.84, 39.82, 34.55, 34.52, 33.52, 33.38,
29.94, 29.21,24.06, 22.07, 22.00, 19.42, 19.36, 15.17, 13.59, 13.23; 1H-1H COSY
(CDCl3, 500Hz): 9.70/7.91 (s, H-e/H-f), 6.98/6.54 (m, H-g/H-14), 6.98/6.34-6.37 (m,
H-g/H-12'), 4.87/3.94 (s, H-a/H-b), 2.06/1.62-1.65 (s, H-4, 4'/H-3, 3'),
1.62-1.65/1.48-1.50 (s, H-3, 3'/H-2, 2'); 1H -13C HETCOR (CDCl3): 9.70/148.48 (w,
H-e/C-e), 7.91/120.52 (w, H-f/C-f), 6.98/137.27 (H-f/C-f), 6.34-6.37/129.17 (w,
H-12'/C-12'), 4.87/56.19 (m, H-a/C-a), 3.94/68.62 (m, H-b/C-b), 3.75/61.60 (m, H-c/C-c),
3.73/73.45 (m, H-d/C-d), 2.14/, 2.08/13.17 (w, H-13a/C-13a), 2.08/15.17 (w, H-9'a/C-9a),
2.06/13.23 (w, H-4, 4'/C-4, 4'), 2.03/24.06 (w, H-9a/C-9a), 1.74/22.01-22.07 (m, H-5a,
5'a/C-5a, 5'a), 1.62-1.65/19.36-19.42 (m, H-3, 3'/C-3, 3'), 1.48-1.50/39.82-39.84 (s, H-2,
2'/C2, 2'), 1.05-1.06/29.21 (s, H-1a, 1b, 1'a, 1'b/C-1a, 1b, 1'a, 1'b).

3
4

2
1a

1
1b

6

7

5
5a
8
9

O
10

9a
11

1'a 1'b
2'

1'

3'
4'

6'

7'

14

5'

g

a

N

11'
8' 9' 10'

e
12'

16

12
13

13a
9'a

O 15

f

b O

c

O
c'

5'a

A2DM (39)

1-(2,2-dimethoxyethyl)-2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1enyl)octa-1,3,5,7-tetraenyl)-4-((1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohex-1enyl)hexa-1,3,5-trienyl)pyridinium

84

A2DM (39): All-trans-retinal (200.0 mg, 0.7 mmol), amino acetaldehyde
dimethyl acetate (32.6 mg, 0.3 mmol), and acetic acid (18.6 μl, 0.3 mmol) were stirred in
ethanol (25.0 ml) at room temperature in the dark for 48 h. The solvent was removed in
vacuo and the residue was purified 2–3 times by column chromatography (silica, eluted
with CH2Cl2 first, then with 10:90:0.01 MeOH:CH2Cl2:CH3COOH) to afford A2DM
(15.8 mg, 8 %) as a dark-red oil. HRMS (ESI+) calcd 636.4775 for [C44H62NO2]+, found
636.4733; UV-vis λmax 338.6 nm, 444.0 nm; 1H-NMR (CDCl3, 500 MHz) δ 9.44 (d, J =
6.5 Hz, 1H), 7.92 (dd, J = 7, 1 Hz, 1H), 7.75 (dd, J = 15.5, 11.5 Hz, 1H), 7.29 (d, J = 1
Hz, 1H), 6.96 (dd, J = 15, 11.5 Hz, 1H), 6.64 (bs, 1H), 6.46-6.54 (m, 3H), 6.16-6.34 (m,
6H), 4.85 (t, J = 5 Hz, 1H), 4.78 (d, J = 5 Hz, 2H), 3.47 (bs, 6H), 2.15 (bs, 1H), 2.02-2.06
(m, 10 H), 1.74 (d, J = 5.5 Hz, 6H), 1.63-1.65 (m, 4H), 1.48-1.51 (m, 4h), 1.06 (d, J = 5
Hz, 6H); 13C-NMR (CDCl3, 125 MHz) δ 176.26, 152.70, 152.44, 147.63, 146.66,
146.47, 140.44, 138.21, 137.88, 137.82, 137.38, 136.80, 134.14, 132.70, 132.00, 131.00,
130.54, 129.37, 128.90, 125.27, 125.18, 120.44, 120.11, 103.56, 57.27, 56.70, 39.82,
34.54, 34.51, 33.51, 33.37, 29.21, 23.18, 22.08, 22.02, 19.44, 19.35, 15.10, 13.56, 13.20;
1

H-1H COSY (CDCl3, 500Hz): 9.44/7.92 (s, H-e/H-f), 7.75/6.64 (s, H-g/H-14),

7.75/6.28-6.34 (s, H-g/H-12'), 2.06/1.63-1.65 (m, H-4, 4'/H-3, 3'), 1.63-1.65/1.48-1.51 (m,
H-3, 3'/H-2, 2'); 1H -13C HETCOR (CDCl3): 9.44/147.63 (w, H-e/C-e), 7.92/120.11 (w,
H-f/C-f), 7.75/137.38 (w, H-g/C-g), 6.64/125.13 (w, H-14/C-14), 6.28-6.34/128.90 (w,
H-12’/C-12’), 4.78/57.25 (w, H-a/C-a), 3.47/56.70 (H-c/C-c), 2.15/13.20 or 13.56 (w,
H-13a/C-13a), 2.06/15.10 (w, H-4, 4'/C-4, 4'), 2.05/23.18 (w, H-9'a/C-9'a), 2.02/33.37 (s,
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H-9a/C-9a), 1.74/22.02-22.08 (s, H-5a, 5'a/C-5a, 5'a), 1.63-1.65/19.35-19.44 (s, H-3,
3'/C3, 3'), 1.50-1.51/39.82 (H-2, 2'/C2, C2'), 1.06/29.21 (s, H-1a, 1b, 1'a, 1'b/C-1a, 1b, 1'a,
1'b). '
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A2DE (40)

1-(2,2-diethoxyethyl)-2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex1-enyl)octa-1,3,5,7-tetraenyl)-4-((1E,3E,5E)-4-methyl-6-(2,6,6trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl)pyridinium

A2DE (40): All-trans-retinal (200.0 mg, 0.7 mmol), amino acetaldehyde diethyl
acetate (41.3 mg, 0.3 mmol), and acetic acid (18.6 μl, 0.3 mmol) were stirred in ethanol
(25.0 ml) at room temperature in the dark for 48 h. The solvent was removed in vacuo
and the residue was purified 2–3 times by column chromatography (silica, eluted with
CH2Cl2 first, then with 10:90:0.01 MeOH:CH2Cl2:CH3COOH) to afford A2DE (20.6 mg,
10 %) as a dark-red oil. HRMS (ESI+) calcd 636.5088 for [C46H66NO2]+, found
664.5068; UV-vis λmax 337.5 nm, 442.3 nm; 1H-NMR (CDCl3, 500 MHz) δ 9.35 (bs,
1H), 7.95 (bs, 1H), 7.76 (dd, J = 14.5, 11.5 Hz, 1H), 7.73, (bs, 1H), 6.95 (dd, J = 15, 11.5
Hz, 1H), 6.72 (bs, 1H), 6.44-6.52 (m, 2H), 6.16-6.33 (m, 6H), 4.99 (bs, 1H), 4.73 (bs,
2H), 3.73-3.78 (m, 2H), 3.59-3.65 (m, 2H), 2.15 (bs, 3H), 2.02-2.05 (m, 10 H), 1.74 (d, J
= 3.5 Hz, 6H), 1.61-1.64 (m, 4H), 1.47-1.49 (m, 4H), 1.16 (t, J = 7 Hz, 6H), 1.05 (d, J =
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3.5 Hz, 6H); 13C-NMR (CDCl3, 125 MHz) δ 176.26, 168.59, 152.70, 152.44, 147.63,
147.53, 146.66, 146.47, 140.44, 138.21, 137.88, 137.78, 137.38, 137.13, 136.98, 134.14,
132.70, 132.00, 131.00, 130.75, 130.65, 130.54, 129.79, 129.37, 128.90, 127.18, 126.18,
125.27, 128.19, 120.64, 120.44, 120.11, 118.29, 103.56, 57.27, 56.70, 39.82, 34.54,
34.51, 33.51, 33.37, 33.73, 29.21, 23.18, 22.08, 22.02, 19.44, 19.35, 15.10, 13.56, 13.20.
1

H-1H COSY (CDCl3, 500Hz): 9.34/7.96 (m, H-e/H-f), 7.76/6.51-6.52 (w, H-g/H-14),

7.76/6.28-6.33 (w, H-g/H-12'), 2.05/1.61-1.64 (s, H-4, 4'/H3, 3'), 1.61-1.64/1.47-1.49 (s,
H-3, 3'/H-2, 2'); 1H -13C HETCOR (CDCl3): 9.34/152.70 (w, H-e/C-e), 7.96/120.11 (w,
H-f/C-f), 7.76/138.21 (w, H-g/C-g), 6.51-6.52/125.27 (w, H-14/C-14), 6.28-6.33/128.90
(w, H-12'/C-12'), 4.73/57.27 (w, H-a/C-a), 2.15/13.56 (w, H-13a/C-13a), 2.05/15.10 (w,
H-4, 4'/C-4, 4'), 2.02/13.20 (w, H-9'a/C-9'a), 2.02/23.18 (s, H-9a/C-9a), 1.74/22.02 or
22.08 (s, H-5a, 5'a/C-5a, 5'a), 1.61-1.64/19.35-19.44 (s, H-3, 3'/C3, 3'),
1.47-1.49/34.51-34.54 (H-2, 2'/C2, C2'), 1.16/15.10 (m, H-d, d'/C-d, d'), 1.05/29.21 (s,
H-1a, 1b, 1'a, 1’b/C-1a, 1b, 1'a, 1'b).
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A2OA (41)

2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-enyl)octa-1,3,5,7tetraenyl)-4-((1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa1,3,5-trienyl)-1-(octan-2-yl)pyridinium

A2OA (41): All-trans-retinal (200.0 mg, 0.7 mmol), 2-octanamine (40.1 mg, 0.3
mmol), and acetic acid (18.6 μl, 0.3 mmol) were stirred in ethanol (25.0 ml) at room
temperature in the dark for 48 h. The solvent was removed in vacuo and the residue was
purified 2–3 times by column chromatography (silica, eluted with CH2Cl2 first, then with
5:95:0.01 MeOH:CH2Cl2:CH3COOH) to afford A2OA (20.5mg, 10%) as a dark-red oil.
HRMS (ESI+) calcd 660.5503 for [C48H70N]+, found 660.5495; UV-vis λmax 340.7 nm,
439.3 nm; 1H-NMR (CDCl3, 500 MHz) δ 7.71 (d, J = 7.5 Hz, 1H ), 8.48 (J = 6.5 Hz,
1H), 7.90 (dd, J = 14.5, 11.5 Hz, 1H), 7.25 (bs, 1H), 6.97 (dd, J = 15, 11.5 Hz, 1H),
6.45-6.53 (m, 2H), 6.16-6.35 (m, 2H), 4.70-4.75 (m, 1H), 2.17 (bs, 3H), 2.02-2.04 (m, 10
H), 1.69-1.74 (m, 11H), 1.61-1.64 (m, 4H), 1.47-1.50 (m, 4H), 1.16-1.25 (m, 6H),
1.02-1.05 (m, 8H), 0.84 (t, J = 7 Hz, 3H); 13C-NMR (CDCl3, 125 MHz) δ 152.41,
150.85, 148.13, 146.88, 16.15, 140.80, 137.86, 137.76, 137.61, 137.30, 136.78, 133.67,
132.63, 131.97, 131.37, 130.61, 129.60, 129.20, 128.79, 125.25, 125.12, 120.11, 118.79,
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65.96, 62.88, 39.81, 34.54, 34.51, 33.49, 33.36, 29.93, 29.21, 22.06, 22.00, 21.01, 19.42,
19.35, 15.18, 13.54, 13.22.
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A2AP (42)

2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-enyl)octa1,3,5,7-tetraenyl)-1-(2-hydroxypropyl)-4-((1E,3E,5E)-4-methyl-6(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl)pyridinium

A2AP (42): All-trans-retinal (200.0 mg, 0.7 mmol), 1-amino-2-propanol (23.3
mg, 0.3 mmol), and acetic acid (18.6 μl, 0.3 mmol) were stirred in ethanol (25.0 ml) at
room temperature in the dark for 48 h. The solvent was removed in vacuo and the residue
was purified 2–3 times by column chromatography (silica, eluted with CH2Cl2 first, then
with 30:70:0.01 MeOH:CH2Cl2:CH3COOH) to afford A2AP (16.2 mg, 8.6 %) as a
dark-red oil. HRMS (ESI+) calcd 606.4669 for [C43H60NO] +, found 606.4675; UV-vis
λmax 326.8 nm, 426 nm; 1HNMR (CDCl3, 500 MHz) δ 9.50 (bs, 1H), 7.63-7.74 (m, 2H),
7.34 (bs, 1H), 6.97 (dd, J = 14.5, 11.5 Hz, 1H), 6.15-6.51 (m, 9H), 4.69 (bs, 1H), 6.45 (d,
J = 11.5 Hz, 1H), 4.06 (bs, 1H), 2.12 (bs, 3H), 2.00-2.07 (m, 10 H), 1.73 (d, dd, J = 5.5
Hz, 6H), 1.61-1.62 (m, 4H), 1.47-1.49 (m, 4H), 1.32 (d, dd, J = 5.5 Hz, 3H), 1.01-1.05
(m, 6H); 13C NMR (CDCl3, 125 MHz) δ 152.41, 150.85, 148.13, 146.88, 146.15, 140.80,
137.86, 137.76, 137.61, 136.78, 133.67, 132.63, 131.97, 131.37, 130.61, 129.61, 129.20,
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128.80, 125.25, 125.12, 120.11, 118.79, 65.96, 62.88, 39.81, 34.54, 34.51, 33.49, 33.36,
29.93, 29.21, 22.06, 22.00, 21.01, 19.42, 19.35, 15.18, 13.36, 13.22.
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S-A2AP (42-S)

2-((1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-enyl)octa-1,3,5,7tetraenyl)-1-((S)-2-hydro-xypropyl-4-((1E,3E,5E)-4-methyl-6-(2,6,6trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl)pyridinium

S-A2AP (42-S): All-trans-retinal (200.0 mg, 0.7 mmol), S-1-amino-2-propanol
(23.3 mg, 0.3 mmol), and acetic acid (18.6 μl, 0.3 mmol) were stirred in ethanol (25.0 ml)
at room temperature in the dark for 48 h. The solvent was removed in vacuo and the
residue was purified 2–3 times by column chromatography (silica, eluted with CH2Cl2
first, then with 30:70:0.01 MeOH:CH2Cl2:CH3COOH) to afford S-A2AP (15.1 mg, 8 %)
as a dark-red oil. HRMS (ESI+) calcd 606.4669 for [C43H60NO]+, found 606.4675;
UV-vis λmax 327.9 nm, 427.5 nm; 1H-NMR (CDCl3, 500 MHz) δ 9.37 (d, J = 5 Hz, 1H ),
7.63-7.75 (m, 2H), 7.37 (d, J = 22.5 Hz, 1H), 6.95-7.05 (m, 1H), 6.45-6.52 (m, 2H),
6.03-6.40 (m, 6H), 4.62 (t, J = 9 Hz, 1H), 4.45 (d, J = 13 Hz, 1H), 4.05 (d, J = 2.5 Hz,
1H), 2.13 (bs, 3H), 1.97-2.11 (m, 10H), 1.73 (d, J = 5.5 Hz, 6H), 1.60-1.63 (m, 4H),
1.45-1.49 (m, 4H), 1.32 (d, J = 6 Hz, 3H), 1.00-1.05 (m, 6H); 13C- NMR (CDCl3, 125
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MHz) δ 178.00, 152.58, 151.00, 147.49, 147.04, 146.53, 146.35, 137.85, 137.75, 137.58,
137.30, 137.07, 136.78, 133.66, 133.49, 132.72, 132.03, 131.45, 130.83, 130.62, 130.02,
129.63, 139.29, 128.84, 126.63, 126.13, 126.21, 120.38, 120.17, 118.77, 116.98, 72.74,
66.00, 64.19, 62.94, 39.81, 34.52, 33.49, 33.35, 29.21, 22.06, 22.00, 19.41, 19.35.

O

ATR dimer (43)

6-methyl-4,6-bis((1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa1,3,5-trienyl)cyclohexa-1,3-dienecarbaldehyde

ATR dimer (43): All-trans-retinal (100.0 mg, 0.4 mmol), 3-amino-1-propanol
(11.7 mg, 0.2 mmol), and acetic acid (9.2 μl, 0.2 mmol) were stirred in ethanol (10.0 ml)
at room temperature in the dark for 48 h. The solvent was removed in vacuo and the
residue was purified by column chromatography (silica, eluted with CH2Cl2) to afford the
ATR dimer (2.9 mg, 3 %) as a yellow oil. HRMS (ESI+) calcd 551.4247 for [C40H54O]+,
found 551.4225; UV-vis 3 λmax 290.3 nm, 432.5 nm; 1H-NMR (CDCl3, 500 MHz) 3 δ
9.46 (s, 1H), 6.94-7.00 (q, J = 11.5 Hz, 1H), 6.82 (d, J = 6.4 Hz, 1H), 5.98-6.45 (m, 9H),
5.83-5.86 (d, J = 15.1 Hz, 1H), 2.66-2.71 (d, J = 16.6 Hz, 1H), 2.40-2.45 (d, J = 17.1 Hz,
1H), 2.02-2.06 (m, 5H), 1.99 (t, J = 6.4 Hz, 2H), 2.02-2.06 (m, 5H), 1.99 (t, J = 6.4 Hz,
2H), 1.85 (s, 3H), 1.73 (s, 3H), 1.67 (s, 3H), 1.56-1.65 (m, 4H), 1.48 (s, 3H), 1.43-1.48
(m, 4H), 1.04 (s, 6H), 0.98 (s, 6H); 13C- NMR (CDCl3, 125 MHz) 3 δ 192.29, 144.45,
144.28, 141.75, 139.83, 138.51, 138.05, 137.53, 132.90, 130.46, 130.35, 129.94, 129.09,
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128.96, 126.51, 123.99, 122.91, 39.87, 39.76, 38.80, 34.43, 33.41, 33.18, 29.22, 29.12,
24.64, 22.03, 21.89, 19.50, 19.45, 13.23, 12.91.
5.4. Blue-Light Irradiation of Pyridinium Bisretinoids
5.4.1. Blue-Light Irradiation of A2P. A2P (15.0 mg, 24.7 mmol) was dissolved
in H2O (2.0 mL) and DMSO (18.0 mL). An aliquot (4.0 mL) of this solution was placed
in a two sided, 10 mm, polystyrene vis-cuvette. The solution was irradiated with fiber
optic illuminator equipped with a blue light (442 nm) interference filter. Samples (100 μL)
were taken for ESI-MS and HPLC analysis every hour for five hours. An HPLC solvent
gradient (20 % H2O with 0.1% TFA to 100 % ACN) was used to elute A2P.
5.4.2. Blue-Light Irradiation of A2EE. A2EE (17.0 mg, 26.7 mmol) was
dissolved in H2O (2.0 mL) and DMSO (18.0 mL). An aliquot (4.0 mL) of this solution
was placed in a two sided, 10 mm, polystyrene vis-cuvette. The solution was irradiated
with fiber optic illuminator equipped with a blue light (442 nm) interference filter.
Samples (100 μL) were taken for ESI-MS and HPLC analysis every hour for five hours.
An HPLC solvent gradient (93.0 % H2O with 0.1% TFA to 100 % ACN) was used to
elute A2EE.
5.4.3. Blue-Light Irradiation of A2DM. A2DM (16.0 mg, 25.1 mmol) was
dissolved H2O (2.0 mL) and DMSO (18.0 mL). An aliquot (4.0 mL) of this solution was
placed in a two sided, 10 mm, polystyrene vis-cuvette. The solution was irradiated with a
fiber optic illuminator equipped with a blue light (442 nm) interference filter. Samples
(100 μL) were taken for ESI-MS and HPLC analysis every hour for three hours. An
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HPLC solvent gradient (20 % H2O with 0.1 % TFA to 100 % ACN) was used to elute
A2DM.
5.5. Cytotoxicity Assays of A2P and A2EE
Sterile, filtered DMSO solutions (20.0 mM) of A2P and A2EE were prepared. Cell
viabilities of the controls were maintained as close to or greater than 95%. The HL-60
cells were grown to selected concentrations (~ 4 X 105 cells/ml) and plated onto two
24-well plates. The cells are incubated with specified concentrations (Chapter 4) of A2P
and A2EE for 24 hours, along with media and DMSO controls. One 24-well plate was
irradiated inside the incubator for the specified times with a fiber optic illuminator
equipped with a blue light (442 nm) interference filter, then allowed to incubate for
another 24 hours. The other plate was incubated for another 24 hours without irradiation.
After incubation, the cell viabilities were monitored using the TBCC or MTT assays.
5.5.1. Trypan Blue Cell Count. Cell suspension (10 μL) was mixed into 0.4%
trypan blue (10 μL). A cover glass was centered over the hemacytometer and the cell/TB
mixture (10 μL) was then added to one chamber. The number of cells per mL and percent
viability were then calculated after viewing under the microscope.
5.5.2. Cell Proliferation Assay.
5.5.2.1. Preparation of MTT solution: To a centrifuge tube (15.0 mL) was added
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (50 mg) dissolved
in 0.1 M phosphate buffer saline (PBS) solution (10.0 mL). The solution was incubated
in a 37℃ water bath for 5 h.
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5.5.2.2. Colorimetric quantitative analysis: Cell solutions (1200 μL/well) were
incubated as described above in 24-well plates, and then half of the solution (600 μL/well)
was removed from the top of each well. MTT solution (90 μL) was added to each well
and incubated for 1-4 hours to allow the cells to convert the substrate into the purplecolored formazan product. Sterile, filtered DMSO (1.2 mL) was added into each well to
stop the reaction. Aliquots (200 μL) were removed from each well and transfered into a
96-well plate. This plate was read using a VMax kinetic microplate reader and the
absorbance was determined at 490 nm.
5.5.3. Some Cell Assay Data.
A2P vs HL-60 30 min Irradiation with 10 μM A2P
10 μM A2P
Item

media

media hv

10 μM A2P

DMSO
DMSO

hv

hv

Data 1

1.144

1.228

0.724

0.505

1.023

1.077

Data 2

1.376

1.162

0.634

0.519

1.153

0.919

Average* 20000

25200

23900

13580

10240

21760

19960

1640.488

466.690

636.396

98.995

919.239

1117.229

Standard
Deviation* 10000

A2EE vs HL-60 30 min Irradiation with 5 μM A2EE
DMSO
Item

media

media hν

5 μM A2EE

5μM A2EE hν

DMSO

hν

Data 1

0.611

0.636

0.675

0.619

0.858

0.806

Data 2

0.655

0.649

0.609

0.602

0.57

0.749

Average* 20000

12660

12850

12840

12210

14280

15550

311.127

91.924

466.690

120.208

2036.470

403.050

Standard
Deviation*
10000
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A2EE vs HL-60 40 min Irradiation with 7 μM A2EE
7μM
Item

media

media hν

7μM A2EE

A2EE hν

DMSO

DMSO hν

Data 1

0.778

0.815

0.687

0.432

0.815

0.920

Data 2

0.783

0.792

0.699

0.593

0.890

0.766

Average*20000

15610

16070

13860

10250

17050

16860

35.360

162.634

84.852

1138.441

530.330

1088.944

Standard
Deviation*10000
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